<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cbl" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cbl</book-part-id>
      <title-group>
        <title>Disorders of Intracellular Cobalamin Metabolism</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Carrillo</surname>
            <given-names>Nuria</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Therapeutics for Rare and Neglected Diseases<break/>National Center for Advancing Translational Sciences<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>carrilln@mail.nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Adams</surname>
            <given-names>David</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Medical Genetics Branch<break/>National Human Genome Research Institute<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>dadams1@mail.nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Venditti</surname>
            <given-names>Charles P</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Genetics and Molecular Biology Branch<break/>National Human Genome Research Institute<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>venditti@mail.nih.gov</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>25</day>
          <month>2</month>
          <year>2008</year>
        </date>
        <date date-type="updated">
          <day>21</day>
          <month>11</month>
          <year>2013</year>
        </date>
        <date date-type="revised">
          <day>11</day>
          <month>8</month>
          <year>2009</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="dcm-ov" document-type="chapter">Dilated Cardiomyopathy Overview</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="donnai" document-type="chapter">Donnai-Barrow Syndrome</related-object>
      <abstract id="cbl.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The clinical manifestations of disorders of intracellular cobalamin metabolism can be highly variable even within a single complementation group. The prototype and best understood is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range, including:</p>
          <list list-type="bullet">
            <list-item>
              <p>Newborns, who can have intrauterine growth retardation (IUGR) and microcephaly;</p>
            </list-item>
            <list-item>
              <p>Infants, who can have poor feeding, failure to thrive, pallor, and neurologic signs, and occasionally hemolytic uremic syndrome (HUS) and/or seizures including infantile spasms;</p>
            </list-item>
            <list-item>
              <p>Toddlers, who can have failure to thrive, poor head growth, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures; and</p>
            </list-item>
            <list-item>
              <p>Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, and/or subacute combined degeneration of the spinal cord.</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of disorders of intracellular cobalamin metabolism relies on clinical, biochemical, complementation group, and molecular genetic data. Urine organic acid analysis and plasma amino acid analysis are the mainstays of biochemical testing. Diagnosis is confirmed by identification of biallelic pathogenic variants in one of the following genes (associated complementation groups indicated in parentheses): <italic toggle="yes">MMACHC</italic> (cblC), <italic toggle="yes">MMADHC</italic> (cblD and cblD variant 1), <italic toggle="yes">MTRR</italic> (cblE), <italic toggle="yes">LMBRD1</italic> (cblF), <italic toggle="yes">MTR</italic> (cblG), and <italic toggle="yes">ABCD4</italic> (cblJ).</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> No therapy completely mitigates all disease manifestations. Critically ill individuals must be stabilized, preferably in consultation with a metabolic specialist, by treating acidosis and reversing catabolism. Treatment of thromboembolic complications (e.g., hemolytic uremic syndrome (HUS) and thrombotic microangiopathy) include initiation of hydroxocobalamin (OHCbl) and betaine or an increase in their doses. Long-term management focuses on improving the metabolic derangement by lowering plasma tHcy and MMA concentrations and maintaining plasma methionine concentrations within the normal range. Gastrostomy tube placement for feeding may be required; infantile spasms, seizures, congenital heart defects, and hydrocephalus are treated using standard protocols.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Early institution of therapy may reduce but not completely prevent primary manifestations. To prevent metabolic decompensations, patients are advised to avoid situations that result in catabolism, such as prolonged fasting and dehydration.</p>
          <p><italic toggle="yes">Surveillance:</italic> During the first year of life, infants may need to be evaluated once or twice a month by a metabolic specialist to assess growth, nutritional status, feeding ability, and developmental and neurocognitive progress. Other evaluations may include ophthalmologic examination for retinal and optic nerve changes in patients with cblC and cblG and if visual symptoms are present.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Prolonged fasting (longer than overnight without dextrose-containing intravenous fluids); dietary protein intake below the recommended dietary allowance (RDA) for age or more than that prescribed by a metabolic specialist; methionine restriction; and the anesthetic nitrous oxide.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> If the pathogenic variants in the family are known, at-risk sibs may be tested prenatally to allow initiation of treatment as soon as possible after birth. If the newborn sib of an affected individual has not undergone prenatal testing, the infant can be tested in the first week of life by urine organic acids, plasma amino acids, measurement of total plasma homocysteine, and acylcarnitine profile analysis for the purpose of early diagnosis and treatment.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>All disorders of intracellular cobalamin metabolism are inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in a family are known. If molecular genetic testing is not possible, prenatal testing for pregnancies at 25% risk is possible by a combination of complementation analysis of cultured amniocytes and measurement of MMA and tHcy concentrations in amniotic fluid using mass spectrometric techniques.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cbl.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="cbl.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_cbl.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disorders of Intracellular Cobalamin Metabolism: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_cbl.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>cblC</p></list-item><list-item><p>cblD</p></list-item><list-item><p>cblD variant 1</p></list-item><list-item><p>cblD variant 2</p></list-item><list-item><p>cblE</p></list-item><list-item><p>cblF</p></list-item><list-item><p>cblG</p></list-item><list-item><p>cblJ</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="cbl.Diagnosis">
        <title>Diagnosis</title>
        <sec id="cbl.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The disorders of intracellular cobalamin metabolism result from deficient synthesis of the coenzymes derived from vitamin B<sub>12</sub>:</p>
          <list list-type="bullet">
            <list-item>
              <p>Adenosylcobalamin (AdoCbl) - the coenzyme for methylmalonyl-CoA mutase enzyme</p>
            </list-item>
            <list-item>
              <p>Methylcobalamin (MeCbl) - the coenzyme for the enzyme methionine synthase (MTR) (<xref ref-type="fig" rid="cbl.F1">Figure 1</xref>)</p>
            </list-item>
          </list>
          <p>This <italic toggle="yes">GeneReview</italic> describes disorders with combined methylmalonic acidemia and homocystinuria caused by AdoCbl and MeCbl deficiency (<xref ref-type="table" rid="cbl.T.disorders_of_intracellular_cobalam">Table 1 - B</xref>) and disorders associated with homocystinuria (MeCbl deficiency) (<xref ref-type="table" rid="cbl.T.disorders_of_intracellular_cobalam">Table 1 - C</xref>). For disorders associated with isolated methylmalonic acidemia (AdoCbl deficiency) (<xref ref-type="table" rid="cbl.T.disorders_of_intracellular_cobalam">Table 1 - A</xref>) see <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">Methylmalonic Acidemia</related-object>).</p>
          <p>The diagnosis of a disorder of intracellular cobalamin metabolism in a symptomatic individual is based on clinical, biochemical, complementation group, and molecular genetic data.</p>
          <p>Since newborn screening (NBS) potentially allows early detection of certain disorders of intracellular cobalamin metabolism (see <xref ref-type="sec" rid="cbl.Testing_Strategy">Testing Strategy</xref>), some affected individuals may be diagnosed prior to the onset of symptoms.</p>
          <table-wrap id="cbl.T.disorders_of_intracellular_cobalam" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Disorders of Intracellular Cobalamin Metabolism by Biochemical Phenotype</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Biochemical Phenotype</th>
                  <th id="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Complementation Group&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1"><bold>A.</bold>
<related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter"><bold>Methylmalonic acidemia</bold></related-object>
<bold>(AdoCbl deficiency)</bold></td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">cblA&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MMAA</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">cblB&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MMAB</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">cblD (variant 2)&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">MMADHC</italic>&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                    <bold>B. Combined methylmalonic acidemia and homocystinuria&#x000a0;<sup>4</sup> (AdoCbl and MeCbl deficiency)</bold>
                  </td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">cblC</td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MMACHC</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">cblD</td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">MMADHC</italic>&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">cblF</td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">LMBRD1</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">cblJ</td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ABCD4</italic>&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <bold>C. Homocystinuria&#x000a0;<sup>4</sup> (MeCbl deficiency)</bold>
                  </td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">cblD (variant 1)</td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">MMADHC</italic>&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">cblE</td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MTRR</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">cblG</td>
                  <td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MTR</italic>
                  </td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note: The terms methylmalonic acidemia/aciduria are interchangeable as are the terms hyperhomocysteinemia/homocystinuria.</p>
              </fn>
              <fn id="cbl.TF.1.1">
                <label>1. </label>
                <p>The nomenclature for inherited disorders of intracellular cobalamin metabolism is based on cellular complementation analysis that defines cobalamin groups A-J (cblA - cblJ). The name of each disorder is prefixed with &#x0201c;cbl&#x0201d; (for cobalamin) followed by a unique capital letter for its complementation group determined by somatic cell analysis (e.g., cblC represents complementation group C).</p>
              </fn>
              <fn id="cbl.TF.1.2">
                <label>2. </label>
                <p>CblA, cblB, and cblD variant 2 are discussed in detail in <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">Methylmalonic Acidemia</related-object> and briefly in <xref ref-type="sec" rid="cbl.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
              </fn>
              <fn id="cbl.TF.1.3">
                <label>3. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.coelho.2008.1454">Coelho et al [2008]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.1.4">
                <label>4. </label>
                <p>The homocystinuria seen in disorders of intracellular cobalamin metabolism is associated with low/normal methionine in contrast to the <related-object link-type="booklink" source-id="gene" document-id="homocystinuria" document-type="chapter">homocystinuria</related-object> seen in cystathionine beta synthase deficiency which is associated with high methionine (see <xref ref-type="fig" rid="cbl.F1">Figure 1</xref>).</p>
              </fn>
              <fn id="cbl.TF.1.5">
                <label>5. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.kim.2012.664">Kim et al [2012]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="cbl.Testing">
          <title>Testing</title>
          <sec id="cbl.Biochemical_Testing">
            <title>Biochemical Testing</title>
            <p>The identification of disorders of intracellular cobalamin metabolism relies first on establishing the biochemical phenotype (described in <xref ref-type="table" rid="cbl.T.disorders_of_intracellular_cobalam">Table 1</xref>) using the following testing (<xref ref-type="table" rid="cbl.T.metabolite_concentrations_in_disor">Table 2</xref>):</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Urine organic acid (UOA) analysis</bold> to detect elevation of methylmalonic acid (MMA). Other secondary metabolites such as 3-hydroxypropionate, methylcitrate, and tiglylglycine may be seen transiently in affected individuals who are ill. Methylglutaconic aciduria can be seen on occasion [<xref ref-type="bibr" rid="cbl.REF.adams.2006">Adams et al 2006</xref>].</p>
                <p>Note: Quantitative serum MMA levels are more accurate than urine organic acid analysis for longitudinal monitoring.</p>
              </list-item>
              <list-item>
                <p><bold>Plasma amino acid (PAA) analysis.</bold> Hypomethioninemia, seen in disorders with defective MeCbl synthesis, helps differentiate disorders of intracellular cobalamin metabolism from other causes of homocystinuria, such as cystathionine beta-synthase deficiency (see <xref ref-type="sec" rid="cbl.Differential_Diagnosis">Differential Diagnosis</xref>, <bold>Cystathionine beta synthase deficiency</bold>).</p>
                <p>Other findings that can be seen on PAA analysis include:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Hyperhomocystinemia and mixed disulfides (which are also excreted in the urine);</p>
                  </list-item>
                  <list-item>
                    <p>Cystathionine (which is also excreted in the urine) in individuals with cblC.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>Total plasma homocysteine (tHcy) analysis</bold> is the preferred method of detecting and monitoring plasma homocysteine concentration in individuals with defective MeCbl synthesis.</p>
                <p>Note: Delays in separating serum from plasma after obtaining a blood sample can artificially increase total homocysteine by as much as 10% an hour [<xref ref-type="bibr" rid="cbl.REF.ubbink.2000.233">Ubbink 2000</xref>, <xref ref-type="bibr" rid="cbl.REF.refsum.2004.3">Refsum et al 2004</xref>].</p>
              </list-item>
            </list>
            <table-wrap id="cbl.T.metabolite_concentrations_in_disor" orientation="portrait" position="anchor">
              <label>Table 2. </label>
              <caption>
                <p>Metabolite Concentrations in Disorders of Intracellular Cobalamin Metabolism</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="2" valign="middle" colspan="2" align="left" scope="colgroup" headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1"/>
                    <th id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Methylmalonic Acid</th>
                    <th id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3">Plasma Homocysteine (tHcy)</th>
                    <th id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4">Plasma Methionine</th>
                  </tr>
                  <tr>
                    <th headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2" id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Urine</th>
                    <th headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2" id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Blood</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <bold>Biochemical Phenotype</bold>
                    </td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="3" valign="middle" align="left" colspan="1">
                      <bold>Comple-<break/>mentation<break/>Group</bold>
                    </td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" valign="middle" colspan="4" align="left" rowspan="1">
                      <bold>Normal Values</bold>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">&#x0003c;4 mmol/mol/Cr&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;0.27 &#x000b5;mol/L&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Total 3-13 &#x000b5;mol/L</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">11-37 nmol/mL</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" valign="middle" colspan="4" align="left" scope="col" rowspan="1">
                      <bold>Values by Biochemical Phenotype</bold>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">AdoCbl deficiency</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">cblA</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" rowspan="3" valign="middle" align="left" colspan="1">100s to low 1000s of mg/g Cr when ill or at presentation; generally ranging from 10s to 100s mg/g Cr during treatment</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" rowspan="2" valign="middle" align="left" colspan="1">100s of &#x000b5;mol/L when ill; 10s of &#x000b5;mol/L when well</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">Within normal limits</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Within normal limits</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" valign="middle" colspan="1" align="left" scope="col" rowspan="1">cblB</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1"/>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">Combined AdoCbl and MeCbl deficiency</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">cblC&#x000a0;<sup>1</sup></td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" valign="middle" colspan="1" align="left" rowspan="1">100s of &#x000b5;mol/L when ill; 1-10 range when well &#x00026; treated&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;100 when ill; <break/>&#x0003c;50 &#x000b5;mol/L when well &#x00026; treated&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Low to normal</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">cblD&#x000a0;<sup>3,&#x000a0;4</sup></td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Can be &#x0003e;1000 mg/g Cr</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">ND</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;100 &#x000b5;mol/L in some variants</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Low to normal</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">cblF&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">200 mmol/mol/Cr when untreated; normal during treatment</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Normal when treated</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Increased when untreated; normal when treated</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">cblJ&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Increased</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Increased</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Increased</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Low to normal</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">MeCbl deficiency</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">cblE&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Normal&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">ND</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;100 &#x000b5;mol/L when ill</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Low&#x000a0;<sup>8</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">cblG&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Normal</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Increased</td>
                    <td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Low&#x000a0;<sup>8</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>ND = not determined</p>
                </fn>
                <fn id="cbl.TF.2.1">
                  <label>1. </label>
                  <p>Standard values have not been exclusively derived from children or neonates. Some laboratories report urine methylmalonic acid (MMA) concentrations in mg/g/Cr (normal: &#x0003c;3 mg/g/Cr) and serum concentrations in nmol/L (normal: &#x0003c;271 nmol/L). The molecular weight of MMA is 118 g/mol.</p>
                </fn>
                <fn id="cbl.TF.2.2">
                  <label>2. </label>
                  <p>Authors' experience with &#x0003e;30 patients</p>
                </fn>
                <fn id="cbl.TF.2.3">
                  <label>3. </label>
                  <p>Values refer to cblD and cblD variant 2. CblD variant 1 may have a different pattern that resembles cblC.</p>
                </fn>
                <fn id="cbl.TF.2.4">
                  <label>4. </label>
                  <p>Individuals with cblD variant 1 [<xref ref-type="bibr" rid="cbl.REF.suormala.2004.42742">Suormala et al 2004</xref>], cblE (methionine synthase reductase), and cblG (methionine synthase) generally have homocystinuria but no methylmalonic acidemia.</p>
                </fn>
                <fn id="cbl.TF.2.5">
                  <label>5. </label>
                  <p>
                    <xref ref-type="bibr" rid="cbl.REF.alfadhel.2011.2571">Alfadhel et al [2011]</xref>
                  </p>
                </fn>
                <fn id="cbl.TF.2.6">
                  <label>6. </label>
                  <p>
                    <xref ref-type="bibr" rid="cbl.REF.kim.2012.664">Kim et al [2012]</xref>
                  </p>
                </fn>
                <fn id="cbl.TF.2.7">
                  <label>7. </label>
                  <p>Mild elevation uncommon [<xref ref-type="bibr" rid="cbl.REF.tuchman.1988.1052">Tuchman et al 1988</xref>]</p>
                </fn>
                <fn id="cbl.TF.2.8">
                  <label>8. </label>
                  <p>
                    <xref ref-type="bibr" rid="cbl.REF.watkins.2014">Watkins &#x00026; Rosenblatt [2014]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec id="cbl.Confirmatory_Testing">
            <title>Confirmatory Testing</title>
            <p>Investigations on cultured fibroblasts obtained from a skin biopsy can help establish the diagnosis of specific disorders of intracellular cobalamin metabolism.</p>
            <p><bold>Complementation group analysis</bold> is a method used to identify the specific defect of intracellular cobalamin metabolism. The complementation groups currently known are cblA, cblB, cblC, cblD, cblE, cblF, cblG and cblJ.</p>
            <p><bold>Molecular genetic testing,</bold> when available, can be more convenient than complementation group analysis in confirming the diagnosis of a disorder of intracellular cobalamin metabolism.</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Single gene testing</bold>. One strategy is to perform sequence analysis of the genes according to which are most commonly mutated in the disorders (<xref ref-type="table" rid="cbl.T.summary_of_molecular_genetic_testi">Table 3</xref>).</p>
                <p>Note: Sequencing of <italic toggle="yes">MMACHC</italic> is likely to be the most cost-effective method to arrive to a diagnosis in a patient in whom cblC is suspected based on clinical findings.</p>
              </list-item>
              <list-item>
                <p><bold>Multi-gene panel</bold>. Another strategy is use of a multi-gene panel that includes the genes of interest. See <xref ref-type="sec" rid="cbl.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
              </list-item>
            </list>
            <table-wrap id="cbl.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
              <label>Table 3. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Disorders of Intracellular Cobalamin Metabolism</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Complementation Group</th>
                    <th id="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Disorders of Intracellular Cobalamin Metabolism Attributed to Mutation of This Gene</th>
                    <th id="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MMACHC</italic>
                    </td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="3" valign="middle" align="left" colspan="1">cblC</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">80%</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants including c.271dupA</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Targeted analysis for pathogenic variants</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">c.271dupA</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Exon or whole-gene deletions / duplications&#x000a0;<sup>5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MMADHC</italic>
                    </td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">cblD <break/>cblD variant 1<break/>cblD variant 2</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">&#x0003c;5%</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Exon or whole-gene deletions / duplications&#x000a0;<sup>5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">MTRR</italic>
                    </td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">cblE</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;5%&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">LMBRD1</italic>
                    </td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">cblF</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">&#x0003c;5%</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">(Multi)exon deletions / duplications&#x000a0;<sup>7</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">MTR</italic>
                    </td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">cblG</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;5%</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">ABCD4</italic>&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">cblJ</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%</td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_cbl.T.summary_of_molecular_genetic_testi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="cbl.TF.3.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="cbl" object-id="cbl.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="cbl.TF.3.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="cbl.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="cbl.TF.3.3">
                  <label>3. </label>
                  <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice-site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="cbl.TF.3.4">
                  <label>4. </label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="cbl.TF.3.5">
                  <label>5. </label>
                  <p>No deletions or duplications involving <italic toggle="yes">MMACHC</italic>, <italic toggle="yes">MMADHC</italic>, and <italic toggle="yes">LMBRD1</italic> have been reported to cause disorders of intracellular cobalamin metabolism.</p>
                </fn>
                <fn id="cbl.TF.3.6">
                  <label>6. </label>
                  <p><xref ref-type="bibr" rid="cbl.REF.homolova.2010.437">Homolova et al [2010]</xref> reported a deep intronic pathogenic variant (c.903+469T&#x0003e;C) in <italic toggle="yes">MTRR</italic>.</p>
                </fn>
                <fn id="cbl.TF.3.7">
                  <label>7. </label>
                  <p>A deletion spanning exon 2 (see Molecular Genetics, <xref ref-type="sec" rid="cbl.LMBRD1"><italic toggle="yes">LMBRD1</italic></xref>)</p>
                </fn>
                <fn id="cbl.TF.3.8">
                  <label>8. </label>
                  <p>
                    <xref ref-type="bibr" rid="cbl.REF.coelho.2012.1152">Coelho et al [2012]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="cbl.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>Confirmation of the diagnosis in a proband.</bold> The algorithm in <xref ref-type="fig" rid="cbl.F2">Figure 2</xref> may assist with the evaluation of a proband in the following clinical scenarios:</p>
          <list list-type="bullet">
            <list-item>
              <p>Newborns from a family with a previously affected sib</p>
            </list-item>
            <list-item>
              <p>Symptomatic individuals, even if newborn screening was reported as normal [<xref ref-type="bibr" rid="cbl.REF.chace.2001.2040">Chace et al 2001</xref>]</p>
            </list-item>
            <list-item>
              <p>Newborn with abnormal newborn screening based on elevated C3 propionylcarnitine or decreased methionine (see <named-content content-type="highlight-1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.acmg.net/StaticContent/ACT/C3.pdf">ACMG ACT Sheets C3</ext-link></named-content> and <named-content content-type="highlight-1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.acmg.net/StaticContent/ACT/Methionine.pdf">Methionine</ext-link></named-content>)</p>
            </list-item>
          </list>
          <p>Note: Detection by newborn screening depends on the C3 and C3/C2 ratio cut-off values used by reference laboratories and availability of detection of low methionine [<xref ref-type="bibr" rid="cbl.REF.chace.2001.2040">Chace et al 2001</xref>, <xref ref-type="bibr" rid="cbl.REF.weisfeldadams.2010.116">Weisfeld-Adams et al 2010</xref>].</p>
          <p><bold>Research molecular genetic testing.</bold> Because new technologies may facilitate gene identification in the near future, participation in research studies may be useful for individuals in whom a specific type of disorder of intracellular cobalamin metabolism cannot be established.</p>
        </sec>
      </sec>
      <sec id="cbl.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="cbl.Clinical_Description">
          <title>Clinical Description</title>
          <p>Disorders of intracellular cobalamin metabolism have a variable phenotype (<xref ref-type="table" rid="cbl.T.manifestations_of_disorders_of_int">Table 4</xref>) and age of onset that is influenced by the severity and location in the pathway of the defect.</p>
          <table-wrap id="cbl.T.manifestations_of_disorders_of_int" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p>Manifestations of Disorders of Intracellular Cobalamin Metabolism</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_1"/>
                  <th id="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2">Manifestations</th>
                  <th id="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3" valign="middle" colspan="4" align="left" scope="colgroup" rowspan="1">Combined AdoCbl and MeCbl Deficiency</th>
                  <th id="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">MeCbl Deficiency</th>
                </tr>
                <tr>
                  <th headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3" id="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">cblC&#x000a0;<sup>1</sup></th>
                  <th headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3" id="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">cblD&#x000a0;<sup>2</sup></th>
                  <th headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3" id="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">cblF&#x000a0;<sup>3</sup></th>
                  <th headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3" id="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">cblJ&#x000a0;<sup>4</sup></th>
                  <th headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4" id="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">cblE&#x000a0;<sup>5</sup></th>
                  <th headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4" id="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">cblG&#x000a0;<sup>5</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_1" rowspan="7" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Perinatal</bold>
                  </td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Intrauterine growth retardation</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Microcephaly</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Hydrops fetalis</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Dysmorphic features</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Congenital heart disease</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Fetal dilated cardiomyopathy</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Hydrocephalus</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_1" rowspan="21" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Infantile &#x00026;<break/>childhood</bold>
                  </td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Acute metabolic decompensation</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Lethargy</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Progressive encephalopathy</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Seizures</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Ataxia</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Hypotonia</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Developmental delay</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Demyelinating Neuropathy</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Microcephaly</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Subdural hematoma</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Feeding difficulties</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Failure to thrive</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Nystagmus</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Retinal degeneration</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Optic atrophy</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Megaloblastic anemia, cytopenias</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Recurrent infections</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Stomatitis, glossitis</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Hemolytic uremic syndrome</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>11</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>12</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Cerebral atrophy</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Transient ischemic attack</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_1" rowspan="13" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Adolescent<break/>&#x00026; adulthood</bold>
                  </td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Progressive encephalopathy</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Leukoencephalopathy</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>13</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Psychosis</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>14</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Dementia</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>14</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Neuropsychiatric symptoms</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>14</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Executive dysfunction</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>13</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Subacute combined degeneration of the spinal cord</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>14</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>15</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Glomerulopathy</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>16</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Thromboembolic microangiopathy</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>17</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deep venous thrombosis</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>14</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Pulmonary thromboembolism</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>18</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Stroke</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>19</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Marfanoid features</td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X&#x000a0;<sup>20</sup></td>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_3 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_1_4 hd_h_cbl.T.manifestations_of_disorders_of_int_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="cbl.TF.4.1">
                <label>1. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.nogueira.2008.475">Nogueira et al [2008]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.2">
                <label>2. </label>
                <p><xref ref-type="bibr" rid="cbl.REF.coelho.2008.1454">Coelho et al [2008]</xref>, <xref ref-type="bibr" rid="cbl.REF.suormala.2004.42742">Suormala et al [2004]</xref></p>
              </fn>
              <fn id="cbl.TF.4.3">
                <label>3. </label>
                <p><xref ref-type="bibr" rid="cbl.REF.alfadhel.2011.2571">Alfadhel et al [2011]</xref>, <xref ref-type="bibr" rid="cbl.REF.gailus.2010.17">Gailus et al [2010]</xref></p>
              </fn>
              <fn id="cbl.TF.4.4">
                <label>4. </label>
                <p><xref ref-type="bibr" rid="cbl.REF.coelho.2012.1152">Coelho et al [2012]</xref>, <xref ref-type="bibr" rid="cbl.REF.kim.2012.664">Kim et al [2012]</xref></p>
              </fn>
              <fn id="cbl.TF.4.5">
                <label>5. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.watkins.2014">Watkins &#x00026; Rosenblatt [2014]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.6">
                <label>6. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.frattini.2010.135">Frattini et al [2010]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.7">
                <label>7. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.cerone.1999.148">Cerone et al [1999]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.8">
                <label>8. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.profitlich.2009.344">Profitlich et al [2009]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.9">
                <label>9. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.francis.2004.420">Francis et al [2004]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.10">
                <label>10. </label>
                <p><xref ref-type="bibr" rid="cbl.REF.gaillard.2008.491">Gaillard et al [2008]</xref>, <xref ref-type="bibr" rid="cbl.REF.gerth.2008.591">Gerth et al [2008]</xref></p>
              </fn>
              <fn id="cbl.TF.4.11">
                <label>11. </label>
                <p><xref ref-type="bibr" rid="cbl.REF.sharma.2007.2097">Sharma et al [2007]</xref>, <xref ref-type="bibr" rid="cbl.REF.kind.2002.327">Kind et al [2002]</xref></p>
              </fn>
              <fn id="cbl.TF.4.12">
                <label>12. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.labrune.1999.734">Labrune et al [1999]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.13">
                <label>13. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.boxer.2005.1431">Boxer et al [2005]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.14">
                <label>14. </label>
                <p><xref ref-type="bibr" rid="cbl.REF.roze.2003.1457">Roze et al [2003]</xref>, <xref ref-type="bibr" rid="cbl.REF.powers.2001.396">Powers et al [2001]</xref></p>
              </fn>
              <fn id="cbl.TF.4.15">
                <label>15. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.carmel.1988.1738">Carmel et al [1988]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.16">
                <label>16. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.brunelli.2002.800">Brunelli et al [2002]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.17">
                <label>17. </label>
                <p><xref ref-type="bibr" rid="cbl.REF.van_hove.2002.195">Van Hove et al [2002]</xref>, <xref ref-type="bibr" rid="cbl.REF.guigonis.2005.588">Guigonis et al [2005]</xref></p>
              </fn>
              <fn id="cbl.TF.4.18">
                <label>18. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.brandstetter.1990.167">Brandstetter et al [1990]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.19">
                <label>19. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.geraghty.1992.934">Geraghty et al [1992]</xref>
                </p>
              </fn>
              <fn id="cbl.TF.4.20">
                <label>20. </label>
                <p>
                  <xref ref-type="bibr" rid="cbl.REF.heil.2007.811">Heil et al [2007]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <sec id="cbl.Combined_Methylmalonic_Acidemia_and">
            <title>Combined Methylmalonic Acidemia and Homocystinuria (cblC, some variants of cblD, cblF, and cblJ)</title>
            <p>cblC, likely the most common of the disorders of intracellular cobalamin metabolism, is the best understood clinically and is described here as a prototype for combined methylmalonic acidemia and homocystinuria. In cblC age of onset ranges from prenatal to adulthood. The infantile presentation is the most frequently recognized.</p>
            <p><bold>Prenatal manifestations.</bold> Intrauterine growth retardation (IUGR) has been seen in infants with cblC [<xref ref-type="bibr" rid="cbl.REF.nogueira.2008.475">Nogueira et al 2008</xref>, <xref ref-type="bibr" rid="cbl.REF.frattini.2010.135">Frattini et al 2010</xref>] and cblF [<xref ref-type="bibr" rid="cbl.REF.alfadhel.2011.2571">Alfadhel et al 2011</xref>]. Other developmental manifestations can include microcephaly [<xref ref-type="bibr" rid="cbl.REF.francis.2004.420">Francis et al 2004</xref>, <xref ref-type="bibr" rid="cbl.REF.smith.2006.138">Smith et al 2006</xref>], congenital heart disease [<xref ref-type="bibr" rid="cbl.REF.profitlich.2009.344">Profitlich et al 2009</xref>], dilated cardiomyopathy, hydrocephalus, and mild dysmorphic features (long facies, flat philtrum and large low-set ears) [<xref ref-type="bibr" rid="cbl.REF.cerone.2000.87">Cerone et al 2000</xref>].</p>
            <p><bold>Infantile presentation.</bold> This severe presentation is progressive and may be lethal unless treated. Infants may present with failure to thrive, poor feeding, and hypotonia in the first two weeks of life or with an acute metabolic derangement (high anion gap metabolic acidosis, ketonuria, and hyperammonemia). The absence of an acute metabolic presentation should not rule out the diagnosis of a disorder of intracellular cobalamin metabolism [<xref ref-type="bibr" rid="cbl.REF.harding.2003.384">Harding et al 2003</xref>]. Untreated infants may have multi-organ involvement, neurologic deterioration, seizures (i.e., infantile spasms), and encephalopathy.</p>
            <p>Some infants present with hemolytic uremic syndrome (HUS) that may be fatal if treatment with daily hydroxocobalamin (OHCbl) is not initiated promptly [<xref ref-type="bibr" rid="cbl.REF.kind.2002.327">Kind et al 2002</xref>, <xref ref-type="bibr" rid="cbl.REF.sharma.2007.2097">Sharma et al 2007</xref>, <xref ref-type="bibr" rid="cbl.REF.carrillocarrasco.2012.103">Carrillo-Carrasco &#x00026; Venditti 2012</xref>].</p>
            <p>Progressive retinopathy typically develops in individuals with infantile cblC. The initial manifestations are &#x0201c;wandering eye movements,&#x0201d; ocular fixation difficulties, and nystagmus. Fundoscopic changes (which can be detected by careful examination as early as the first month of life) are characterized by abnormal macular pigmentation which evolves classically over the next few years into a "bull's-eye" macula and a pigmentary retinopathy and maculopathy.</p>
            <p>Late-onset presentations of cblC and other inborn errors of cobalamin metabolism do not typically have ophthalmologic complications. Optic atrophy has been described in cblG [<xref ref-type="bibr" rid="cbl.REF.poloschek.2005.497">Poloschek et al 2005</xref>].</p>
            <p><bold>Early presentation (first years of life).</bold> Failure to thrive, poor head growth, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures are typical.</p>
            <p><bold>Adolescent and adult presentation.</bold> Individuals with this presentation usually have predominant <bold>neurologic and neuropsychiatric</bold> manifestations including the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Neuropsychiatric symptoms (behavioral and personality changes, social withdrawal, visual and auditory hallucinations, delirium, psychosis)</p>
              </list-item>
              <list-item>
                <p>Progressive cognitive decline (regression, deterioration in school or work performance, impaired dexterity and memory, speech difficulties, dementia, and lethargy) which is frequently described in the absence of other manifestations [<xref ref-type="bibr" rid="cbl.REF.powers.2001.396">Powers et al 2001</xref>, <xref ref-type="bibr" rid="cbl.REF.boxer.2005.1431">Boxer et al 2005</xref>, <xref ref-type="bibr" rid="cbl.REF.benomran.2007.979">Ben-Omran et al 2007</xref>, <xref ref-type="bibr" rid="cbl.REF.thauvinrobinet.2008.725">Thauvin-Robinet et al 2008</xref>]</p>
              </list-item>
              <list-item>
                <p>Subacute combined degeneration of the spinal cord [<xref ref-type="bibr" rid="cbl.REF.bodamer.2001.1113">Bodamer et al 2001</xref>, <xref ref-type="bibr" rid="cbl.REF.benomran.2007.979">Ben-Omran et al 2007</xref>, <xref ref-type="bibr" rid="cbl.REF.tsai.2007.2430">Tsai et al 2007</xref>]. In some cases, improvement has been reported after initiation of treatment [<xref ref-type="bibr" rid="cbl.REF.thauvinrobinet.2008.725">Thauvin-Robinet et al 2008</xref>].</p>
              </list-item>
            </list>
            <p>Brain MRI may reveal leukodystrophy ranging from isolated periventricular white matter hyperintensities to diffuse white matter loss [<xref ref-type="bibr" rid="cbl.REF.rossi.2001.554">Rossi et al 2001</xref>, <xref ref-type="bibr" rid="cbl.REF.longo.2005.366">Longo et al 2005</xref>].</p>
          </sec>
          <sec id="cbl.Isolated_Homocystinuria_cblE_cblG_so">
            <title>Isolated Homocystinuria (cblE, cblG, some variants of cblD)</title>
            <p>Methylcobalamin deficiency secondary to methionine synthase reductase deficiency (cblE) is more common than methionine synthase deficiency (cblG) and cblD variant 1.</p>
            <p>Most children with cblE present in the first two years of life with severe failure to thrive, megaloblastic anemia, and neurologic manifestations; isolated megaloblastic anemia may also be seen.</p>
            <p>Individuals with cblG characteristically present in the first year of life with neurologic manifestations and megaloblastic anemia; however, phenotypic variability ranges from an infantile to an adult presentation. Neurologic manifestations may include weakness, hypotonia, seizures, mental status changes, and adult-onset leukoencephalopathy. Other unusual presentations of adult-onset cblG include megaloblastic anemia and progressive weakness (initially diagnosed as multiple sclerosis) [<xref ref-type="bibr" rid="cbl.REF.carmel.1988.1738">Carmel et al 1988</xref>] and neuropsychiatric illness [<xref ref-type="bibr" rid="cbl.REF.hill.2004.116">Hill et al 2004</xref>]. Optic nerve atrophy has been described in cblG [<xref ref-type="bibr" rid="cbl.REF.poloschek.2005.497">Poloschek et al 2005</xref>].</p>
            <p>Individuals with cblD variant 1 leading to isolated methylcobalamin deficiency had cognitive impairment, neurologic signs, and megaloblastic anemia [<xref ref-type="bibr" rid="cbl.REF.suormala.2004.42742">Suormala et al 2004</xref>]. Thromboembolic complications, including clinically significant thrombophilia causing renal artery thrombosis [<xref ref-type="bibr" rid="cbl.REF.watkins.1989.427">Watkins &#x00026; Rosenblatt 1989</xref>], HUS, and pulmonary hypertension [<xref ref-type="bibr" rid="cbl.REF.labrune.1999.734">Labrune et al 1999</xref>] have been described in patients with this biochemical phenotype.</p>
          </sec>
        </sec>
        <sec id="cbl.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype/phenotype correlations observed include the following:</p>
          <p>
            <bold>cblC</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Early-onset, severe disease is associated with the <italic toggle="yes">MMACHC</italic> c.271dupA or the <italic toggle="yes">MMACHC</italic> c.331 C&#x0003e;T (p.Arg111Ter) pathogenic variants in the homozygous or compound heterozygote state.</p>
            </list-item>
            <list-item>
              <p>Late-onset disease is usually associated the <italic toggle="yes">MMACHC</italic> c.394C&#x0003e;T (p.Arg132Ter) and <italic toggle="yes">MMACHC</italic> c.482G&#x0003e;A (p.Arg161Gln) pathogenic variants [<xref ref-type="bibr" rid="cbl.REF.morel.2006.315">Morel et al 2006</xref>, <xref ref-type="bibr" rid="cbl.REF.nogueira.2008.475">Nogueira et al 2008</xref>, <xref ref-type="bibr" rid="cbl.REF.lernerellis.2009.1072">Lerner-Ellis et al 2009</xref>, <xref ref-type="bibr" rid="cbl.REF.wang.2009.189">Wang et al 2009</xref>]. It may also be associated with <italic toggle="yes">MMACHC</italic> c.271dupA if patients are compound heterozygotes for c.394C&#x0003e;T, c.347T&#x0003e;C, c.440 G&#x0003e;C, or c.482G&#x0003e;A [<xref ref-type="bibr" rid="cbl.REF.morel.2006.315">Morel et al 2006</xref>].</p>
            </list-item>
          </list>
          <p><bold>cblD.</bold> The location of pathogenic variants within <italic toggle="yes">MMADHC</italic> correlates with the type of enzyme deficiency:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>AdoCbl deficiency.</bold> Pathogenic variants are generally nonsense and frame-shifting variants in exons 3 and 4, encoding the region of the protein necessary for AdoCbl synthesis.</p>
            </list-item>
            <list-item>
              <p><bold>MeCbl deficiency.</bold> Pathogenic variants are missense variants in exons 6 and 8, encoding the region of the protein necessary for MeCbl synthesis.</p>
            </list-item>
            <list-item>
              <p><bold>AdoCbl and MeCbl deficiency.</bold> Pathogenic variants occur in the middle of the protein (exon 5, exon 8, and intron 7) [<xref ref-type="bibr" rid="cbl.REF.stucki.2012.1410">Stucki et al 2012</xref>].</p>
            </list-item>
          </list>
          <p><bold>cblE</bold> caused by the <italic toggle="yes">MTRR</italic> c.1361C&#x0003e;T (p.Ser545Leu) Iberian variant has a milder phenotype than other reported variants in <italic toggle="yes">MTRR</italic> and no evident neurologic involvement [<xref ref-type="bibr" rid="cbl.REF.zavadakova.2002.461">Zavadakova et al 2002</xref>].</p>
          <p>Clear genotype-phenotype correlations have not been described for cblF, cblG, or cblJ.</p>
        </sec>
        <sec id="cbl.Prevalence">
          <title>Prevalence</title>
          <p>The true prevalence of the disorders of intracellular cobalamin metabolism is unknown.</p>
          <p>The incidence of cblC has been estimated at 1:200,000 births. Recently, newborn screening suggested an incidence closer to 1:100,000 in New York State and of 1:60,000 in California, where an incidence of 1:37,000 was estimated in the Hispanic population [<xref ref-type="bibr" rid="cbl.REF.cusmanoozog.2007.227">Cusmano-Ozog et al 2007</xref>, <xref ref-type="bibr" rid="cbl.REF.weisfeldadams.2010.116">Weisfeld-Adams et al 2010</xref>].</p>
          <p>Fewer than forty cases have been described for cblE and cblG, and fewer than 20 cases each for cblD and cblF.</p>
        </sec>
      </sec>
      <sec id="cbl.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">MMACHC, MMADHC, LMBRD1</italic>, <italic toggle="yes">MTR, MTRR</italic>, or <italic toggle="yes">ABCD4</italic>.</p>
      </sec>
      <sec id="cbl.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The following disorders may cause clinical manifestations and laboratory abnormalities similar to those seen in disorders of intracellular cobalamin metabolism:</p>
        <p>
          <bold>Disorders causing both methylmalonic acidemia and homocystinuria</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Vitamin B<sub>12</sub> deficiency.</bold> Individuals with vitamin B<sub>12</sub> deficiency can have methylmalonic acidemia and homocystinuria, as can the newborns of mothers who have vitamin B<sub>12</sub> deficiency. To establish the diagnosis of vitamin B<sub>12</sub> deficiency, it is necessary to measure serum vitamin B<sub>12</sub> concentrations in both affected newborns and their mothers.</p>
            <p>B<sub>12</sub> deficiency can occur in a breast-fed infant of a vegan mother and in an infant born to a mother with subclinical pernicious anemia. The mother may not necessarily have a very low serum concentration of vitamin B<sub>12</sub>. Maternal vitamin B<sub>12</sub> deficiency can result in elevated methylmalonic acid level in an infant with findings that range from severe encephalopathy [<xref ref-type="bibr" rid="cbl.REF.higginbottom.1978.317">Higginbottom et al 1978</xref>] to elevated propionylcarnitine detected by newborn screening [<xref ref-type="bibr" rid="cbl.REF.chace.2001.2040">Chace et al 2001</xref>].</p>
            <p>Intramuscular replacement therapy to normalize vitamin B<sub>12</sub> serum concentration reverses the metabolic abnormality.</p>
          </list-item>
          <list-item>
            <p><bold>Imerslund Gr&#x000e4;sbeck syndrome.</bold> Features of this autosomal recessive disorder may include poor cobalamin absorption, abnormal renal tubular protein reabsorption, and urinary tract malformations. Biallelic pathogenic variants in one of two genes that encode intrinsic factor receptor components have been implicated: <italic toggle="yes">CUBN</italic> (encoding cubulin) and <italic toggle="yes">AMN</italic> (encoding amnionless) [<xref ref-type="bibr" rid="cbl.REF.gr_sbeck.2006.17">Gr&#x000e4;sbeck 2006</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Transcobalamin II deficiency.</bold> Transcobalamin II (distinguished from transcobalamin I AKA haptocorrin) is required for the movement of cobalamin from intestinal enterocytes into cells throughout the body. Transcobalamin II deficiency, a rare condition, is characterized by the infantile onset of megaloblastic anemia, failure to thrive, neurologic disease, and immunologic disease. Serum cobalamin concentrations are generally normal with a reduced (untreated) unsaturated B<sub>12</sub> binding capacity (UBBS) and a reduced level of transcobalamin II (the latter detected by an immunoassay) [<xref ref-type="bibr" rid="cbl.REF.kaikov.1991.841">Kaikov et al 1991</xref>, <xref ref-type="bibr" rid="cbl.REF.rosenblatt.2001">Rosenblatt &#x00026; Fenton 2001</xref>].</p>
          </list-item>
        </list>
        <p>
          <bold>Disorders causing primarily isolated homocystinuria</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="homocystinuria" document-type="chapter"><bold>Cystathionine beta synthase (CBS) deficiency</bold></related-object> (classic homocystinuria) is a disorder of homocysteine catabolism with a Marfan syndrome-like phenotype, soft skin, lens dislocation, developmental delays/cognitive impairment, and thromboembolism. CBS deficiency is progressive with onset typically in childhood. Biochemically it is characterized by elevated serum concentration of methionine and decreased serum concentration of cysteine. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><bold>Methylenetetrahydrofolate reductase (MTHFR) deficiency</bold> is a defect in folate-dependent methylation pathways that results in diminished conversion of homocysteine to methionine. The biochemical hallmark is moderate homocystinuria with low to normal plasma methionine levels. In contrast to methionine biosynthetic defects like cblE and cblG, megaloblastic anemia does not occur. The clinical course is characterized by varying severity, cognitive impairment, and white-matter disease [<xref ref-type="bibr" rid="cbl.REF.fenton.2001">Fenton et al 2001</xref>]. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><bold>Mild homocystinuria</bold> can result from folate deficiency, vitamin B<sub>12</sub> deficiency, or mild pathogenic variants in enzymes in remethylation enzymes.</p>
          </list-item>
        </list>
        <p>
          <bold>Disorders causing primarily methylmalonic acidemia</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p>Disorders associated with isolated methylmalonic acidemia include methylmalonic acidemia caused by mutation of <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">methylmalonyl-CoA mutase</related-object> (<italic toggle="yes">MUT</italic>), <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">cblA</related-object> (<italic toggle="yes">MMAA</italic>), and <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">cblB</related-object> (<italic toggle="yes">MMAB</italic>); <related-object link-type="booklink" source-id="gene" document-id="sucla2-def" document-type="chapter">SUCLA2 deficiency</related-object> [<xref ref-type="bibr" rid="cbl.REF.carrozzo.2007.862">Carrozzo et al 2007</xref>, <xref ref-type="bibr" rid="cbl.REF.ostergaard.2007.853">Ostergaard et al 2007</xref>]; &#x0201c;benign methylmalonic acidemia&#x0201d; [<xref ref-type="bibr" rid="cbl.REF.sniderman.1999.675">Sniderman et al 1999</xref>, <xref ref-type="bibr" rid="cbl.REF.martens.2002.219">Martens et al 2002</xref>]; Reye-like syndrome [<xref ref-type="bibr" rid="cbl.REF.chang.2000.295">Chang et al 2000</xref>]; and combined malonic and methylmalonic acidemia (CMAMMA) caused by mutation of <italic toggle="yes">ACSF3</italic> [<xref ref-type="bibr" rid="cbl.REF.sloan.2011.883">Sloan et al 2011</xref>].</p>
          </list-item>
          <list-item>
            <p>For a more detailed description of other entities with isolated methylmalonic acidemia, see <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">Methylmalonic Acidemia</related-object>.</p>
          </list-item>
        </list>
      </sec>
      <sec id="cbl.Management">
        <title>Management</title>
        <sec id="cbl.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with a disorder of intracellular cobalamin metabolism, the following evaluations are recommended.</p>
          <p>In an unstable patient:</p>
          <list list-type="bullet">
            <list-item>
              <p>Serial metabolic evaluations of blood gases, electrolytes, glucose, ammonia, liver function, total and direct bilirubin, renal function, lactate dehydrogenase, plasma amino acids (methionine), plasma methylmalonic acid (MMA), and total plasma homocysteine (tHcy) to guide acute management until the patient stabilizes</p>
            </list-item>
            <list-item>
              <p>Complete blood count (CBC) with differential to evaluate for megaloblastic anemia, cytopenias</p>
            </list-item>
            <list-item>
              <p>Peripheral blood smear to evaluate for the presence of schistocytes, in the presence of other manifestations of hemolytic uremic syndrome (HUS)</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing to identify pathogenic variants, if not previously performed, to aid in genetic counseling and prediction of disease severity</p>
            </list-item>
          </list>
          <p>Once the patient becomes stable:</p>
          <list list-type="bullet">
            <list-item>
              <p>Clinical assessment of growth parameters, head circumference, ability to feed, developmental status, and neurologic status</p>
            </list-item>
            <list-item>
              <p>Laboratory assessment of nutritional status (electrolytes, albumin, prealbumin, plasma amino acids, vitamin levels [including thiamine and 25-hydroxyvitamin D], and trace minerals) and renal function; complete blood count to monitor for cytopenias</p>
            </list-item>
            <list-item>
              <p>Echocardiogram</p>
            </list-item>
            <list-item>
              <p>EEG and brain MRI in symptomatic individuals</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination</p>
            </list-item>
          </list>
        </sec>
        <sec id="cbl.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Prognosis is poor in patients with early-onset cblC who are undiagnosed and untreated [<xref ref-type="bibr" rid="cbl.REF.rosenblatt.1997.528">Rosenblatt et al 1997</xref>]. Institution of therapy during acute illness results in rapid improvement of clinical, biochemical, and hematologic manifestations in patients with early- and late-onset cblC [<xref ref-type="bibr" rid="cbl.REF.bartholomew.1988.32">Bartholomew et al 1988</xref>, <xref ref-type="bibr" rid="cbl.REF.rosenblatt.1997.528">Rosenblatt et al 1997</xref>, <xref ref-type="bibr" rid="cbl.REF.bodamer.2001.1113">Bodamer et al 2001</xref>, <xref ref-type="bibr" rid="cbl.REF.tomaske.2001.511">Tomaske et al 2001</xref>, <xref ref-type="bibr" rid="cbl.REF.kind.2002.327">Kind et al 2002</xref>, <xref ref-type="bibr" rid="cbl.REF.van_hove.2002.195">Van Hove et al 2002</xref>, <xref ref-type="bibr" rid="cbl.REF.fowler.2008.350">Fowler et al 2008</xref>].</p>
          <p>Parenteral hydroxocobalamin (OHCbl) is the mainstay of therapy and should be instituted as soon as a disorder of intracellular cobalamin metabolism is suspected. Infants are started with daily 1.0 mg intramuscular or subcutaneous injections. Patients with cblC are often highly responsive to this therapy.</p>
          <p>Patients with elevated tHcy should also receive betaine (250 mg/kg/day) and folate or folinic acid.</p>
          <p><bold>Acute metabolic decompensation</bold>. Although less common in the disorders of intracellular cobalamin metabolism than in <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">methylmalonic acidemia</related-object>, severe acidotic/ketotic crises due to profound methylmalonic acidemia do occur. Such critically ill individuals should be managed in consultation with a metabolic specialist. MedicAlert<sup>&#x000ae;</sup> bracelets and emergency treatment protocols outlining fluid and electrolyte therapy should be available for all affected individuals.</p>
          <p>Treatment includes volume replacement with isotonic solutions containing high (10%-12.5%) glucose to reverse catabolism, correction of metabolic acidosis with sodium bicarbonate, and prompt reintroduction of feedings &#x02014; preferably enterally, but parenterally if enteral route cannot be established.</p>
          <p><bold>Thromboembolic complications</bold> a cause of mortality in cblC are likely associated with increasing plasma concentrations of tHcy [<xref ref-type="bibr" rid="cbl.REF.carrillocarrasco.2012.103">Carrillo-Carrasco &#x00026; Venditti 2012</xref>]. The proper management of thromboembolic complications, such as hemolytic uremic syndrome (HUS) and thrombotic microangiopathy, should include initiation of OHCbl and betaine or an increase in their doses [<xref ref-type="bibr" rid="cbl.REF.van_hove.2002.195">Van Hove et al 2002</xref>, <xref ref-type="bibr" rid="cbl.REF.sharma.2007.2097">Sharma et al 2007</xref>].</p>
          <p><bold>Long-term management</bold>. The goals of long-term management include improving the metabolic derangement by lowering plasma tHcy and MMA concentrations and maintaining plasma methionine concentrations within the normal range. These are accomplished by:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Parenteral OHCbl.</bold> The most experience derives from the treatment of patients with cblC. Infants are usually started at a daily dose of 1.0 mg (~0.3 mg/kg/d) of OHCbl given IM or SQ. Parenteral OHCbl (not the cyanocobalamin form or oral form) is the only effective preparation. Placement of a SQ catheter that minimizes cutaneous punctures [<xref ref-type="bibr" rid="cbl.REF.freehauf.2011">Freehauf et al 2011</xref>] and pre-filled injections may increase compliance.</p>
              <p>Weight-appropriate adjustment of the OHCbl dose is recommended and can be attained by the ability to concentrate OHCbl up to 30 mg/mL. Further titration of the dose may be empirically adjusted as needed for worsening clinical manifestations [<xref ref-type="bibr" rid="cbl.REF.van_hove.2002.195">Van Hove et al 2002</xref>] or for metabolic control of plasma tHcy, MMA, or methionine concentrations [<xref ref-type="bibr" rid="cbl.REF.carrillocarrasco.2009.728">Carrillo-Carrasco et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Betaine.</bold> Oral betaine (starting at ~250 mg/kg/day) is recommended in patients with defective MeCbl production (cblC, cblD, cblE, cblF, cblG, and cblJ). Betaine augments the non-methionine synthase-dependent conversion of homocysteine to methionine (however, this is not uniformly accepted). Optimal dosing and monitoring have not been adequately established.</p>
            </list-item>
            <list-item>
              <p><bold>Folate and folinic acid.</bold> Folic acid and folinic acid can potentially augment remethylation and may help improve plasma tHcy and methionine concentrations. Folinic acid may be preferred as it crosses the blood brain barrier more efficiently than folic acid. The adult dose of folate is 1.0 mg by mouth per day, titratable down to 0.5 mg for maintenance. Doses for children and infants are available in the Harriet Lane Handbook [<xref ref-type="bibr" rid="cbl.REF.tschudy.2012">Tschudy &#x00026; Arcara 2012</xref>] and other common reference texts.</p>
            </list-item>
            <list-item>
              <p><bold>Dietary management.</bold> Patients may be able to tolerate a normal diet: the use of a low-protein diet is under debate and needs further clinical studies to clarify the benefits of its use.</p>
              <p>Most importantly, methionine restriction should be avoided, as hypomethioninemia can be detrimental [<xref ref-type="bibr" rid="cbl.REF.ribes.1990.412">Ribes et al 1990</xref>, <xref ref-type="bibr" rid="cbl.REF.rossi.2001.554">Rossi et al 2001</xref>, <xref ref-type="bibr" rid="cbl.REF.de_bie.2009.266">De Bie et al 2009</xref>].</p>
              <p>Gastrostomy tube placement may be required in the present of feeding difficulties and failure to thrive.</p>
            </list-item>
          </list>
          <p>Other therapeutic considerations that have not been fully validated:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Methionine supplementation.</bold> Hypomethioninemia is usually responsive to appropriate treatment with OHCbl and betaine. The need for exogenous methionine supplementation may be minimized by these strategies, as the efficacy of this therapy is uncertain [<xref ref-type="bibr" rid="cbl.REF.smith.2006.138">Smith et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Pyridoxine.</bold> Vitamin B<sub>6</sub> is a cofactor for <related-object link-type="booklink" source-id="gene" document-id="homocystinuria" document-type="chapter">cystathionine beta synthase</related-object> and, therefore has been proposed as a means of maximizing the removal of homocysteine. Persons with disorders of intracellular cobalamin metabolism generally do not respond to pyridoxine unless they have a dietary deficiency.</p>
            </list-item>
            <list-item>
              <p><bold>Levocarnitine.</bold> Indicated for low plasma carnitine levels</p>
            </list-item>
          </list>
          <p>Treatment of infantile spasms, seizures, congenital heart defects, and hydrocephalus is done in a routine manner.</p>
        </sec>
        <sec id="cbl.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>Early institution of therapy may reduce but not completely prevent primary manifestations.</p>
          <p>To prevent metabolic decompensations, patients should be advised to avoid situations that result in catabolism, such as prolonged fasting and dehydration. Of note, during an intercurrent illness patients may be treated with glucose-containing IV fluid.</p>
          <p>Flu prevention (i.e., immunization) should be a routine part of health maintenance.</p>
        </sec>
        <sec id="cbl.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Antiplatelet doses of aspirin may be given to patients with isolated homocystinuria to decrease the risk for thrombosis [<xref ref-type="bibr" rid="cbl.REF.brunelguitton.2010.s409">Brunel-Guitton et al 2010</xref>].</p>
        </sec>
        <sec id="cbl.Surveillance">
          <title>Surveillance</title>
          <p>The following evaluations are performed at different intervals depending on age and disease severity.</p>
          <p>During the first year of life, infants may need to be evaluated once or twice a month by a metabolic specialist.</p>
          <p>Clinical evaluation should include assessment of:</p>
          <list list-type="bullet">
            <list-item>
              <p>Growth including weight, linear growth, and head circumference;</p>
            </list-item>
            <list-item>
              <p>Nutritional status;</p>
            </list-item>
            <list-item>
              <p>Feeding ability;</p>
            </list-item>
            <list-item>
              <p>Developmental and neurocognitive progress, as age-appropriate.</p>
            </list-item>
          </list>
          <p>Laboratory evaluation should include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Metabolic studies: urine organic acids, plasma MMA concentration, plasma amino acids (methionine), plasma tHcy concentration;</p>
            </list-item>
            <list-item>
              <p>Complete blood count (CBC) to monitor for cytopenias;</p>
            </list-item>
            <list-item>
              <p>Nutritional studies, if indicated: electrolytes, albumin, prealbumin, plasma amino acids, vitamin levels (including thiamine and 25-hydroxyvitamin D), and trace minerals.</p>
            </list-item>
          </list>
          <p>Routine evaluations should include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Ophthalmologic evaluation for retinal and optic nerve changes in patients with cblC and cblG and if visual symptoms are present;</p>
            </list-item>
            <list-item>
              <p>Neurologic evaluations for early signs of psychomotor retardation, behavioral disturbances, seizures, and myelopathy;</p>
            </list-item>
            <list-item>
              <p>Brain MRI and/or EEG as clinically indicated.</p>
            </list-item>
          </list>
        </sec>
        <sec id="cbl.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Potentially exacerbating circumstances:</p>
          <list list-type="bullet">
            <list-item>
              <p>Prolonged fasting (longer than overnight without dextrose-containing intravenous fluids)</p>
            </list-item>
            <list-item>
              <p>Dietary protein intake below the recommended dietary allowance (RDA) for age or more than that prescribed by a metabolic specialist</p>
            </list-item>
            <list-item>
              <p>Methionine restriction. Methionine-free formulas given to infants with methylmalonic acidemia should be avoided as the decreased methionine intake may worsen hypomethioninemia in patients with decreased methionine production.</p>
            </list-item>
            <list-item>
              <p>Nitrous oxide, an anesthetic that is potentially toxic as it depletes the body stores of vitamin B<sub>12</sub> and inhibits methionine synthase activity [<xref ref-type="bibr" rid="cbl.REF.abels.1990.128">Abels et al 1990</xref>, <xref ref-type="bibr" rid="cbl.REF.drummond.1994.3742">Drummond &#x00026; Matthews 1994</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="cbl.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>If the pathogenic variants in the family are known, at-risk sibs may be tested prenatally to allow initiation of treatment as soon as possible after birth.</p>
          <p>If the newborn sibling of an affected individual has not undergone prenatal testing, the infant can be tested in the first week of life by urine organic acids, plasma amino acids, measurement of total plasma homocysteine, and acylcarnitine profile analysis for the purpose of early diagnosis and treatment. If the pathogenic variants in the family are known, molecular genetic testing can be used to confirm the diagnosis.</p>
          <p>See <xref ref-type="sec" rid="cbl.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cbl.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>A good pregnancy outcome was reported in a woman with cblC treated with OHCbl 1.0 mg IM, folic acid 5.0 mg per day, aspirin 80 mg per day, levocarnitine, and low-protein diet [<xref ref-type="bibr" rid="cbl.REF.brunelguitton.2010.s409">Brunel-Guitton et al 2010</xref>].</p>
          <p>Prenatal therapy of an affected fetus by administration of intramuscular OHCbl to the mother may decrease developmental abnormalities and improve neurocognitive outcome [<xref ref-type="bibr" rid="cbl.REF.huemer.2005.469">Huemer et al 2005</xref>, <xref ref-type="bibr" rid="cbl.REF.trefz.2012">Trefz et al 2012</xref>] but does not appear to affect the ophthalmologic outcome [<xref ref-type="bibr" rid="cbl.REF.patton.2000.151">Patton et al 2000</xref>]. The dose and frequency of administration of IM OHCbl has not been established. Favorable outcomes of prenatal treatment have been reported by using dosages between 1 to 10 mg per day, 2-3 times a week, starting as early as 15 weeks&#x02019; gestational age [<xref ref-type="bibr" rid="cbl.REF.huemer.2005.469">Huemer et al 2005</xref>, <xref ref-type="bibr" rid="cbl.REF.trefz.2012">Trefz et al 2012</xref>].</p>
        </sec>
        <sec id="cbl.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="cbl.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cbl.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>All of the disorders of intracellular cobalamin metabolism are inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="cbl.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one mutated allele).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with a disorder of intracellular cobalamin metabolism are obligate heterozygotes (carriers) for a pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="cbl.Carrier_Detection">
          <title>Carrier Detection</title>
          <p><bold>Molecular genetic testing.</bold> If the pathogenic variants in an affected family member are known, carrier testing using molecular genetic techniques is possible.</p>
          <p><bold>Biochemical genetic testing</bold> is not reliable for carrier testing.</p>
        </sec>
        <sec id="cbl.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="cbl.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="cbl.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk for a disorder of intracellular cobalamin metabolism and preimplantation genetic diagnosis are possible options.</p>
          <p>See <xref ref-type="sec" rid="cbl.Pregnancy_Management">Pregnancy Management</xref> for information on prenatal therapy.</p>
          <p><bold>Biochemical testing.</bold> If molecular genetic testing is not possible, prenatal testing for pregnancies at 25% risk for a disorder of intracellular cobalamin metabolism is possible by a combination of:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complementation analysis of cultured amniocytes [<xref ref-type="bibr" rid="cbl.REF.morel.2005.160">Morel et al 2005</xref>, <xref ref-type="bibr" rid="cbl.REF.watkins.2014">Watkins &#x00026; Rosenblatt 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Measurement of MMA and tHcy concentrations in amniotic fluid using mass spectrometric techniques [<xref ref-type="bibr" rid="cbl.REF.morel.2005.160">Morel et al 2005</xref>, <xref ref-type="bibr" rid="cbl.REF.watkins.2014">Watkins &#x00026; Rosenblatt 2014</xref>].</p>
            </list-item>
          </list>
          <p>Note: The most prudent recommendation is to perform both metabolite analysis AND complementation assays of cultured CVS or amniocytes.</p>
        </sec>
      </sec>
      <sec id="cbl.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cbl.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="cbl.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>See <xref ref-type="fig" rid="cbl.F1">Figure1</xref>.</p>
          <sec id="cbl.MMACHC">
            <title>
              <italic toggle="yes">MMACHC</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">MMACHC</italic> is 11 kb and comprises five exons [<xref ref-type="bibr" rid="cbl.REF.lernerellis.2006.93">Lerner-Ellis et al 2006</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cbl" object-id="cbl.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> More than 50 pathogenic variants have been identified in persons with cblC.</p>
            <list list-type="bullet">
              <list-item>
                <p>In individuals of European ancestry, the c.271dupA frameshift variant (reference sequence NM_015506.2) accounts for approximately 40% of disease alleles [<xref ref-type="bibr" rid="cbl.REF.lernerellis.2009.1072">Lerner-Ellis et al 2009</xref>]. This variant results in a change of amino acid 91 from arginine to lysine followed by a frameshift causing a premature stop codon (pathogenic variant NP_056321.2:p.Arg91LysfsTer140) [<xref ref-type="bibr" rid="cbl.REF.lernerellis.2006.93">Lerner-Ellis et al 2006</xref>].</p>
              </list-item>
              <list-item>
                <p>The c.609G&#x0003e;A (p.Trp203Ter) nonsense variant is common in Chinese [<xref ref-type="bibr" rid="cbl.REF.liu.2010.621">Liu et al 2010</xref>]; the c.331C&#x0003e;T (p.Arg111Ter) in Cajuns and French Canadians [<xref ref-type="bibr" rid="cbl.REF.lernerellis.2009.1072">Lerner-Ellis et al 2009</xref>]; and the c.394C&#x0003e;T (p.Arg132Ter) variant in people of Indian and Middle Eastern ancestry [<xref ref-type="bibr" rid="cbl.REF.lernerellis.2009.1072">Lerner-Ellis et al 2009</xref>].</p>
              </list-item>
            </list>
            <p><bold>Normal gene product.</bold> The methylmalonic aciduria and homocystinuria type C protein is 282 amino acids and has a predicted molecular weight of 37.1 kd. The C-terminal region may fold similarly to TonB, a bacterial protein involved in energy transduction for cobalamin uptake. A putative vitamin B<sub>12</sub>-binding pocket may also be present.</p>
            <p><bold>Abnormal gene product.</bold> Defects in MMACHC disrupt its ability to process newly internalized cobalamins in the cytosol [<xref ref-type="bibr" rid="cbl.REF.hannibal.2009.260">Hannibal et al 2009</xref>].</p>
          </sec>
          <sec id="cbl.MMADHC">
            <title>
              <italic toggle="yes">MMADHC</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">MMADHC</italic>, previously known as <italic toggle="yes">C2orf25</italic>, is 18 kb and comprises eight exons [<xref ref-type="bibr" rid="cbl.REF.coelho.2008.1454">Coelho et al 2008</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cbl" object-id="cbl.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> There are no clearly identified common disease-causing variants. The pathogenic variants described to date are either missense or truncating (nonsense or frameshift) variants.</p>
            <list list-type="bullet">
              <list-item>
                <p>Studies of individuals with cblD suggest that variants in exons 3 and 4 (c.57_64delCTCTTTAG, c.60insAT, c.133dupG, c.160C&#x0003e;T, and c.228dupG) encoding for the N-terminus of the protein cause AdoCbl deficiency (variant 2 cblD) [<xref ref-type="bibr" rid="cbl.REF.coelho.2008.1454">Coelho et al 2008</xref>, <xref ref-type="bibr" rid="cbl.REF.plesa.2011.139">Plesa et al 2011</xref>, <xref ref-type="bibr" rid="cbl.REF.stucki.2012.1410">Stucki et al 2012</xref>].</p>
              </list-item>
              <list-item>
                <p>Missense variants in exons 6 and 8 (c.545C&#x0003e;A, c.737A&#x0003e;G, c.746A&#x0003e;G, c.776T&#x0003e;C) encoding the C-terminus cause MeCbl deficiency (variant 1).</p>
              </list-item>
              <list-item>
                <p>Truncating variants in exons 5 and 8 and intron 7 (c.419dupA, c.683&#x0003e;G, c.696+1_4delGTGA, c.748C&#x0003e;T) caused combined AdoCbl and MeCbl deficiency.</p>
              </list-item>
            </list>
            <p><bold>Normal gene product.</bold> The <italic toggle="yes">MMADHC</italic> product is predicted to have 296 amino acids with a calculated molecular mass of 32.8 kd and has domains responsible for mitochondrial targeting, AdoCbl synthesis, and MeCbl synthesis [<xref ref-type="bibr" rid="cbl.REF.stucki.2012.1410">Stucki et al 2012</xref>]. There is an N-terminal mitochondrial leader sequence and a predicted B<sub>12</sub> binding sequence [<xref ref-type="bibr" rid="cbl.REF.coelho.2008.1454">Coelho et al 2008</xref>]. The C-terminus is thought to guide vitamin B<sub>12</sub> to methionine synthase [<xref ref-type="bibr" rid="cbl.REF.plesa.2011.139">Plesa et al 2011</xref>].</p>
            <p><bold>Abnormal gene product.</bold> The type and localizations of pathogenic variants within the protein is thought to determine whether the synthesis of AdoCbl, MeCbl, or both is affected. Studies have indicated a protein truncation. Pathogenic variants in the mitochondrial targeting sequencing (position 1-61) affect AdoCbl synthesis.</p>
          </sec>
          <sec id="cbl.LMBRD1">
            <title>
              <italic toggle="yes">LMBRD1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">LMBRD1</italic> is 121 kb and comprises 16 exons [<xref ref-type="bibr" rid="cbl.REF.rutsch.2009.234">Rutsch et al 2009</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cbl" object-id="cbl.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold>
<xref ref-type="bibr" rid="cbl.REF.rutsch.2009.234">Rutsch et al [2009]</xref> studied 12 unrelated individuals with cblF confirmed by complementation analysis. A 1-bp deletion, c.1056delG, was seen on 18 independent alleles, suggesting a founder effect; this variant causes a frameshift yielding a premature stop codon in exon 11 [<xref ref-type="bibr" rid="cbl.REF.rutsch.2009.234">Rutsch et al 2009</xref>].</p>
            <p>Altogether five different DNA variants accounted for 22 of 24 observed pathogenic variants.</p>
            <p>A 6785-bp deletion spanning exon 2 has been reported [<xref ref-type="bibr" rid="cbl.REF.miousse.2011.505">Miousse et al 2011</xref>].</p>
            <p><bold>Normal gene product.</bold> The probable lysosomal cobalamin transporter LMBR1 domain-containing protein 1 is 540 amino acids and has a predicted molecular weight of 61.3 kd (the longest isoform). The predicted protein structure includes nine transmembrane regions and multiple potential glycosylation sites. The protein has been shown by immunocytofluorescene to colocalize with the lysosomal marker LAMP1. The protein is predicted to be a lysosomal membrane transporter; however, the exact ligand remains to be identified [<xref ref-type="bibr" rid="cbl.REF.rutsch.2009.234">Rutsch et al 2009</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants affect the defective release of cobalamin from lysosomes.</p>
          </sec>
          <sec id="cbl.MTR">
            <title>
              <italic toggle="yes">MTR</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">MTR</italic> is 105.24 kb and comprises 33 exons [<xref ref-type="bibr" rid="cbl.REF.brody.1999.324">Brody et al 1999</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cbl" object-id="cbl.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> More than 20 pathogenic variants have been identified.</p>
            <list list-type="bullet">
              <list-item>
                <p>The most common disease-causing allele in persons with cblG is a missense variant c.3518C&#x0003e;T (p.Pro1173Leu), accounting for 40% of alleles [<xref ref-type="bibr" rid="cbl.REF.watkins.2002.143">Watkins et al 2002</xref>].</p>
              </list-item>
              <list-item>
                <p>A subset of severe pathogenic variants including deletions (c.12-13delGC, c.381delA, c.2101delT, c.2112-2113delTC, c.2669-2670delTG, c.2796-2800delAAGTC), nonsense variants (p.Arg585Ter, p.Glu1204Ter) [<xref ref-type="bibr" rid="cbl.REF.watkins.2002.143">Watkins et al 2002</xref>], and IVS3-166A&#x0003e;G are thought to result in premature translation termination and mRNA instability [<xref ref-type="bibr" rid="cbl.REF.wilson.1998.409">Wilson et al 1998</xref>, <xref ref-type="bibr" rid="cbl.REF.watkins.2002.143">Watkins et al 2002</xref>].</p>
              </list-item>
              <list-item>
                <p><xref ref-type="bibr" rid="cbl.REF.leclerc.1996.1867">Leclerc et al [1996]</xref> identified two pathogenic variants specifically near the cobalamin binding domain.</p>
              </list-item>
            </list>
            <p><bold>Normal gene product.</bold> The MTR enzyme has 1265 amino acids and weighs 140.5 kd. There are at least three functional domains:</p>
            <list list-type="bullet">
              <list-item>
                <p>The 38-kd C-terminal domain binds AdoMet.</p>
              </list-item>
              <list-item>
                <p>A domain comprising amino acids 650 to 896 includes the binding domain for the required cofactor methylcobalamin.</p>
              </list-item>
              <list-item>
                <p>The 70-kd N-terminal domain binds homocysteine and methyltetrahydrofolate.</p>
              </list-item>
            </list>
            <p>The latter two activities may be on separate domains within this region [<xref ref-type="bibr" rid="cbl.REF.goulding.1997.8082">Goulding et al 1997</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants are expected to decrease enzymatic activity.</p>
          </sec>
          <sec id="cbl.MTRR">
            <title>
              <italic toggle="yes">MTRR</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">MTRR</italic> is 31.95 kb and comprises 15 exons [<xref ref-type="bibr" rid="cbl.REF.leclerc.1998.3059">Leclerc et al 1998</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cbl" object-id="cbl.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p>
              <bold>Pathogenic allelic variants</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>The most common disease-causing allele, accounting for 25% of alleles, is a deep intronic variant (c.903+469T&#x0003e;C) [<xref ref-type="bibr" rid="cbl.REF.homolova.2010.437">Homolova et al 2010</xref>].</p>
              </list-item>
              <list-item>
                <p>The c.1361C&#x0003e;T (p.Ser545Leu) variant is common in persons of Iberian ancestry. Reports suggest a milder phenotype with no neurologic involvement [<xref ref-type="bibr" rid="cbl.REF.zavadakova.2002.461">Zavadakova et al 2002</xref>].</p>
              </list-item>
              <list-item>
                <p>Other pathogenic variants have been described [<xref ref-type="bibr" rid="cbl.REF.leclerc.1998.3059">Leclerc et al 1998</xref>, <xref ref-type="bibr" rid="cbl.REF.zavadakova.2002.461">Zavadakova et al 2002</xref>]. Most reported pathogenic variants have been non-conservative missense variants. 903&#x0003e;904ins140 is likely to be a splice-affecting variant in intron 6 of MTRR [<xref ref-type="bibr" rid="cbl.REF.zavadakova.2002.461">Zavadakova et al 2002</xref>].</p>
              </list-item>
            </list>
            <p><bold>Normal gene product.</bold> The MTRR protein contains 725 amino acids and has a mass of 80.4 kd. It shares 38% sequence identity with human cytochrome P450 reductase [<xref ref-type="bibr" rid="cbl.REF.leclerc.1998.3059">Leclerc et al 1998</xref>]. MTRR has some chaperone-like activity with regard to MTR [<xref ref-type="bibr" rid="cbl.REF.yamada.2006.9476">Yamada et al 2006</xref>]. A mitochondrial isoform of MTRR has been predicted [<xref ref-type="bibr" rid="cbl.REF.leclerc.1999.75">Leclerc et al 1999</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants are expected to decrease enzymatic activity</p>
          </sec>
          <sec id="cbl.ABCD4">
            <title>
              <italic toggle="yes">ABCD4</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">ABCD4</italic> is 16 kb and comprises 19 exons [<xref ref-type="bibr" rid="cbl.REF.holzinger.1998.238">Holzinger et al 1998</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cbl" object-id="cbl.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> Missense (c.423C&#x0003e;G [p.Asn141Lys], c.956A&#x0003e;G [p.Tyr319Cys]), frameshift (c.1746_1747insCT [p.Glu583LeufsTer9]), and exon-skipping variants (c.542+1G&#x0003e;T [exon 5 skipping], c.1456G&#x0003e;T [exon 13, 14 skipping]) have been identified [<xref ref-type="bibr" rid="cbl.REF.coelho.2012.1152">Coelho et al 2012</xref>, <xref ref-type="bibr" rid="cbl.REF.kim.2012.664">Kim et al 2012</xref>].</p>
            <p>c.542+1G&#x0003e;T results in the skipping of exon 5 which encodes a transmembrane domain, and c.1456G&#x0003e;T results in skipping of exons 13 and 14 in the cytosolic nucleotide binding domain [<xref ref-type="bibr" rid="cbl.REF.kim.2012.664">Kim et al 2012</xref>].</p>
            <p><bold>Normal gene product.</bold> The ABCD4 protein contains 606 amino acids and has a mass of 73 kd [<xref ref-type="bibr" rid="cbl.REF.shani.1997.1925">Shani et al 1997</xref>]. It is an ATP-binding cassette (ABC) transporter that colocalizes with lysosomal proteins LAMP1 and LMBRD1 (cblF). It is thought that its ATPase activity may be involved in the intracellular processing of cobalamin [<xref ref-type="bibr" rid="cbl.REF.coelho.2012.1152">Coelho et al 2012</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Pathogenic variants are expected to affect the lysosomal transport of cobalamin into the cytoplasm [<xref ref-type="bibr" rid="cbl.REF.coelho.2012.1152">Coelho et al 2012</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="cbl.References">
        <title>References</title>
        <sec id="cbl.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cbl.Literature_Cited.reflist0">
            <ref id="cbl.REF.abels.1990.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abels</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kroes</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ermens</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Kapel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoester</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spijkers</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindemans</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Anti-leukemic potential of methyl-cobalamin inactivation by nitrous oxide.</article-title>
                <source>Am J Hematol.</source>
                <year>1990</year>
                <volume>34</volume>
                <fpage>128</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">2187335</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.adams.2006">
              <mixed-citation publication-type="confproc">Adams D, Brooks B, Sloan J, Filiano J, Levy H, Venditti C. Long-term follow-up of a 21 y/o female with methylcobalamin-treated methionine synthase deficiency. Program #1346. New Orleans, LA: American Society of Human Genetics 56th Annual Meeting. 2006.</mixed-citation>
            </ref>
            <ref id="cbl.REF.alfadhel.2011.2571">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alfadhel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lillquist</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Junker</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockler-Ipsiroglu</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Eighteen-year follow-up of a patient with cobalamin F disease (cblF): report and review.</article-title>
                <source>Am J Med Genet A</source>
                <volume>155A</volume>
                <fpage>2571</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21910240</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.bartholomew.1988.32">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bartholomew</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batshaw</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roe</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valle</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francomano</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Therapeutic approaches to cobalamin-C methylmalonic acidemia and homocystinuria.</article-title>
                <source>J Pediatr.</source>
                <year>1988</year>
                <volume>112</volume>
                <fpage>32</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">3257264</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.benomran.2007.979">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ben-Omran</surname>
                    <given-names>TI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blaser</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feigenbaum</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Late-onset cobalamin-C disorder: a challenging diagnosis.</article-title>
                <source>Am J Med Genet A</source>
                <volume>143A</volume>
                <fpage>979</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">17431913</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.bodamer.2001.1113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bodamer</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appel</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beaudet</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Adult-onset combined methylmalonic aciduria and homocystinuria (cblC).</article-title>
                <source>Neurology</source>
                <volume>56</volume>
                <fpage>1113</fpage>
                <pub-id pub-id-type="pmid">11320193</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.boxer.2005.1431">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boxer</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finley</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>BL</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment.</article-title>
                <source>Neurology</source>
                <volume>64</volume>
                <fpage>1431</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15851736</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.brandstetter.1990.167">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brandstetter</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinhouse</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Splaingard</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>TT</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>Cor pulmonale as a complication of methylmalonic acidemia and homocystinuria (Cbl-C type).</article-title>
                <source>Am J Med Genet</source>
                <volume>36</volume>
                <fpage>167</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">2368803</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.brody.1999.324">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brody</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chines</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musick</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molloy</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swanson</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirke</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghosh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mills</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Methionine synthase: high-resolution mapping of the human gene and evaluation as a candidate locus for neural tube defects.</article-title>
                <source>Mol Genet Metab</source>
                <volume>67</volume>
                <fpage>324</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">10444343</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.brunelguitton.2010.s409">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brunel-Guitton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Treatment of cobalamin C (cblC) deficiency during pregnancy.</article-title>
                <source>J Inherit Metab Dis</source>
                <year>2010</year>
                <volume>33</volume>
                <supplement>Suppl 3</supplement>
                <fpage>S409</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">20830523</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.brunelli.2002.800">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brunelli</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyers</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guttenberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Cobalamin C deficiency complicated by an atypical glomerulopathy.</article-title>
                <source>Pediatr Nephrol</source>
                <volume>17</volume>
                <fpage>800</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">12376806</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.carmel.1988.1738">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carmel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodman</surname>
                    <given-names>SI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Hereditary defect of cobalamin metabolism (cblG mutation) presenting as a neurologic disorder in adulthood.</article-title>
                <source>N Engl J Med</source>
                <volume>318</volume>
                <fpage>1738</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">2897628</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.carrillocarrasco.2012.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carrillo-Carrasco</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2012</year>
                <volume>35</volume>
                <fpage>91</fpage>
                <lpage>102</lpage>
                <pub-id pub-id-type="pmid">21748409</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.carrillocarrasco.2009.728">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carrillo-Carrasco</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valle</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamosh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Hydroxocobalamin dose escalation improves metabolic control in cblC.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>32</volume>
                <fpage>728</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">19821145</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.carrillocarrasco.2012.103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carrillo-Carrasco</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes.</article-title>
                <source>J Inherit Metab Dis.</source>
                <volume>35</volume>
                <fpage>103</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">21748408</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.carrozzo.2007.862">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carrozzo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steuerwald</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucioli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deodato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Giandomenico</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franke</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluijtmans</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meschini</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piemonte</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodenburg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Rooij</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermunt-de Koning</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>862</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">17301081</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.cerone.1999.148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cerone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minniti</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piana</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armani</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susco</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertolini</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Screening for hyperhomocysteinemia in young adults with premature coronary artery disease.</article-title>
                <source>Southeast Asian J Trop Med Public Health.</source>
                <year>1999</year>
                <volume>30</volume>
                <supplement>Suppl 2</supplement>
                <fpage>148</fpage>
                <pub-id pub-id-type="pmid">11400754</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.cerone.2000.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cerone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiaffino</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caruso</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Facial anomalies in combined methylmalonic aciduria and homocystinuria.</article-title>
                <source>Am J Med Genet</source>
                <volume>95</volume>
                <fpage>87</fpage>
                <pub-id pub-id-type="pmid">11074504</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.chace.2001.2040">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chace</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiPerna</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalas</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naylor</surname>
                    <given-names>EW</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns.</article-title>
                <source>Clin Chem</source>
                <volume>47</volume>
                <fpage>2040</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11673377</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.chang.2000.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwu</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hou</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ni</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Metabolic disorders mimicking Reye's syndrome.</article-title>
                <source>J Formos Med Assoc</source>
                <volume>99</volume>
                <fpage>295</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10870312</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.coelho.2012.1152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miousse</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fung</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>du Moulin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buers</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frapolli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robenek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;hne</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longo</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mengel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoubridge</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majewski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutsch</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in ABCD4 cause a new inborn error of vitamin B<sub>12</sub> metabolism.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>1152</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22922874</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.coelho.2008.1454">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerner-Ellis</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbold</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Gene identification for the cblD defect of vitamin B<sub>12</sub> metabolism.</article-title>
                <source>N Engl J Med.</source>
                <year>2008</year>
                <volume>358</volume>
                <fpage>1454</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">18385497</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.cusmanoozog.2007.227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cusmano-Ozog</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholas</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Packman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cederbaum</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Cobalamin C disease identified by newborn screening: The California experience. In: Program and abstracts for the SIMD annual meeting.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2007</year>
                <volume>90</volume>
                <fpage>227</fpage>
                <lpage>65</lpage>
              </element-citation>
            </ref>
            <ref id="cbl.REF.de_bie.2009.266">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Bie</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nizard</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <article-title>Fetal dilated cardiomyopathy: an unsuspected presentation of methylmalonic aciduria and hyperhomocystinuria, cblC type.</article-title>
                <source>Prenat Diagn.</source>
                <year>2009</year>
                <volume>29</volume>
                <fpage>266</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">19248038</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.drummond.1994.3742">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drummond</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <article-title>Nitrous oxide inactivation of cobalamin-dependent methionine synthase from Escherichia coli: characterization of the damage to the enzyme and prosthetic group.</article-title>
                <source>Biochemistry.</source>
                <year>1994</year>
                <volume>33</volume>
                <fpage>3742</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">8142374</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.fenton.2001">
              <mixed-citation publication-type="book">Fenton WA, Gravel RA, Rosenblatt DS. Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease</italic>. 8 ed. McGraw-Hill, NY; 2001:2165-93.</mixed-citation>
            </ref>
            <ref id="cbl.REF.fowler.2008.350">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Causes of and diagnostic approach to methylmalonic acidurias.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>31</volume>
                <fpage>350</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">18563633</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.francis.2004.420">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Francis</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calver</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnfield</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalton</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Champion</surname>
                    <given-names>MP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>An infant with methylmalonic aciduria and homocystinuria (cblC) presenting with retinal haemorrhages and subdural haematoma mimicking non-accidental injury.</article-title>
                <source>Eur J Pediatr</source>
                <volume>163</volume>
                <fpage>420</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">15221473</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.frattini.2010.135">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frattini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fusco</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ucchino</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tavazzi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Della Giustina</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Early onset methylmalonic aciduria and homocystinuria cblC type with demyelinating neuropathy.</article-title>
                <source>Pediatr Neurol</source>
                <volume>43</volume>
                <fpage>135</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20610126</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.freehauf.2011">
              <mixed-citation publication-type="confproc">Freehauf CL, Wiman J, Wright E, Van Hove JL, SPector E, Gallagher R, Thomas JA. Use and benefit of a subcutaneous indwelling catheter for cobalamin administration in B<sub>12</sub>-responsive methylmalonic acidemia. Poster session. Pacific Grove, CA: Society for Inherited Metabolic Disorders Annual Meeting. 2011.</mixed-citation>
            </ref>
            <ref id="cbl.REF.gaillard.2008.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gaillard</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthieu</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borruat</surname>
                    <given-names>FX</given-names>
                  </name>
                </person-group>
                <article-title>Retinal dysfunction in combined methylmalonic aciduria and homocystinuria (Cblc) disease: a spectrum of disorders.</article-title>
                <source>Klin Monbl Augenheilkd</source>
                <year>2008</year>
                <volume>225</volume>
                <fpage>491</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18454408</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.gailus.2010.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gailus</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malerczyk-Aktas</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toliat</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittkampf</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennermann</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutsch</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>A novel mutation in LMBRD1 causes the cblF defect of vitamin B<sub>12</sub> metabolism in a Turkish patient.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2010</year>
                <volume>33</volume>
                <fpage>17</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">20127417</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.geraghty.1992.934">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perlman</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayflick</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casella</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valle</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Cobalamin C defect associated with hemolytic-uremic syndrome.</article-title>
                <source>J Pediatr</source>
                <volume>120</volume>
                <fpage>934</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">1593355</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.gerth.2008.591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gerth</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feigenbaum</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>AV</given-names>
                  </name>
                </person-group>
                <article-title>Ocular phenotype in patients with methylmalonic aciduria and homocystinuria, cobalamin C type.</article-title>
                <source>J AAPOS</source>
                <year>2008</year>
                <volume>12</volume>
                <fpage>591</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18848477</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.goulding.1997.8082">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goulding</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Postigo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Cobalamin-dependent methionine synthase is a modular protein with distinct regions for binding homocysteine, methyltetrahydrofolate, cobalamin, and adenosylmethionine.</article-title>
                <source>Biochemistry</source>
                <volume>36</volume>
                <fpage>8082</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">9201956</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.gr_sbeck.2006.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gr&#x000e4;sbeck</surname>
                    <given-names>R.</given-names>
                  </name>
                </person-group>
                <article-title>Imerslund-Gr&#x000e4;sbeck syndrome (selective vitamin B(12) malabsorption with proteinuria).</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2006</year>
                <volume>1</volume>
                <fpage>17</fpage>
                <pub-id pub-id-type="pmid">16722557</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.guigonis.2005.588">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guigonis</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fremeaux-Bacchi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraudier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borderie</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massy</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mougenot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deschenes</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation.</article-title>
                <source>Am J Kidney Dis</source>
                <volume>45</volume>
                <fpage>588</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">15754282</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.hannibal.2009.260">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hannibal</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brasch</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banerjee</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobsen</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Processing of alkylcobalamins in mammalian cells: A role for the MMACHC (cblC) gene product.</article-title>
                <source>Mol Genet Metab</source>
                <volume>97</volume>
                <fpage>260</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19447654</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.harding.2003.384">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pillers</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steiner</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottiglieri</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debley</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>MK</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Potential for misdiagnosis due to lack of metabolic derangement in combined methylmalonic aciduria/hyperhomocysteinemia (cblC) in the neonate.</article-title>
                <source>J Perinatol</source>
                <volume>23</volume>
                <fpage>384</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12847533</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.heil.2007.811">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heil</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogeveen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluijtmans</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dijken</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Berg</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blom</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Marfanoid features in a child with combined methylmalonic aciduria and homocystinuria (CblC type).</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>30</volume>
                <fpage>811</fpage>
                <pub-id pub-id-type="pmid">17768669</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.higginbottom.1978.317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Higginbottom</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweetman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nyhan</surname>
                    <given-names>WL</given-names>
                  </name>
                </person-group>
                <year>1978</year>
                <article-title>A syndrome of methylmalonic aciduria, homocystinuria, megaloblastic anemia and neurologic abnormalities in a vitamin B<sub>12</sub>-deficient breast-fed infant of a strict vegetarian.</article-title>
                <source>N Engl J Med</source>
                <volume>299</volume>
                <fpage>317</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">683264</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.hill.2004.116">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lukonis</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korson</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinstein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thall</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Neuropsychiatric illness in a patient with cobalamin G disease, an inherited disorder of vitamin B<sub>12</sub> metabolism.</article-title>
                <source>Harv Rev Psychiatry</source>
                <volume>12</volume>
                <fpage>116</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">15204806</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.holzinger.1998.238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holzinger</surname>
                    <given-names>A.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roscher</surname>
                    <given-names>A. A.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landgraf</surname>
                    <given-names>P.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichtner</surname>
                    <given-names>P.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kammerer</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Genomic organization and chromosomal localization of the human peroxisomal membrane protein-1-like protein (PXMP1-L) gene encoding a peroxisomal ABC transporter.</article-title>
                <source>FEBS Lett.</source>
                <volume>426</volume>
                <fpage>238</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">9599016</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.homolova.2010.437">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Homolova</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zavadakova</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doktor</surname>
                    <given-names>TK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroeder</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andresen</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The deep intronic c.903+469T&#x0003e;C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.</article-title>
                <source>Hum Mutat</source>
                <volume>31</volume>
                <fpage>437</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">20120036</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.huemer.2005.469">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huemer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simma</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodamer</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>JO</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Prenatal and postnatal treatment in cobalamin C defect.</article-title>
                <source>J Pediatr</source>
                <volume>147</volume>
                <fpage>469</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">16227032</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.kaikov.1991.841">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaikov</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wadsworth</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>PC</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Transcobalamin II deficiency: case report and review of the literature.</article-title>
                <source>Eur J Pediatr</source>
                <volume>150</volume>
                <fpage>841</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">1743216</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.kim.2012.664">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuh-Lian Hwu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahiminiya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majewski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Late onset of symptoms in an atypical patient with the cblJ inborn error of vitamin B(12) metabolism: Diagnosis and novel mutation revealed by exome sequencing.</article-title>
                <source>Mol Genet Metab</source>
                <volume>107</volume>
                <fpage>664</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23141461</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.kind.2002.327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kind</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaicker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kane</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period.</article-title>
                <source>J Pediatr Hematol Oncol</source>
                <volume>24</volume>
                <fpage>327</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11972107</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.labrune.1999.734">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Labrune</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zittoun</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duvaltier</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trioche</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquet</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niaudet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odievre</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency.</article-title>
                <source>Eur J Pediatr</source>
                <volume>158</volume>
                <fpage>734</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10485306</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.leclerc.1996.1867">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leclerc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campeau</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goyette</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adjalla</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eydoux</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders.</article-title>
                <source>Hum Mol Genet</source>
                <volume>5</volume>
                <fpage>1867</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">8968737</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.leclerc.1999.75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leclerc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odievre</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizenga</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Molecular cloning, expression and physical mapping of the human methionine synthase reductase gene.</article-title>
                <source>Gene</source>
                <volume>240</volume>
                <fpage>75</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">10564814</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.leclerc.1998.3059">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leclerc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dumas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gafuik</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heng</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rommens</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>95</volume>
                <fpage>3059</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">9501215</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.lernerellis.2009.1072">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lerner-Ellis</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anastasio</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loewy</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurd</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grundberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pastinen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations.</article-title>
                <source>Hum Mutat.</source>
                <year>2009</year>
                <volume>30</volume>
                <fpage>1072</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">19370762</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.lernerellis.2006.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lerner-Ellis</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tirone</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pawelek</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dore</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiwara</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moras</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosack</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunbar</surname>
                    <given-names>GV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonicka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forgetta</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobson</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leclerc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoubridge</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coulton</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lepage</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rommens</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>93</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">16311595</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.liu.2010.621">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiang</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsiao</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>TT</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria.</article-title>
                <source>Journal of human genetics</source>
                <volume>55</volume>
                <fpage>621</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20631720</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.longo.2005.366">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Longo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fariello</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannata</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boenzi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genovese</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deodato</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>MRI and 1H-MRS findings in early-onset cobalamin C/D defect.</article-title>
                <source>Neuropediatrics</source>
                <volume>36</volume>
                <issue>6</issue>
                <fpage>366</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">16429376</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.martens.2002.219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martens</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Meer</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spaapen</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Unexplained familial benign methylmalonic aciduria.</article-title>
                <source>Eur J Pediatr</source>
                <volume>161</volume>
                <fpage>219</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">12014390</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.miousse.2011.505">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miousse</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Novel splice site mutations and a large deletion in three patients with the cblF inborn error of vitamin B<sub>12</sub> metabolism.</article-title>
                <source>Mol Genet Metab</source>
                <volume>102</volume>
                <fpage>505</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21303734</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.morel.2006.315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerner-Ellis</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations.</article-title>
                <source>Mol Genet Metab</source>
                <volume>88</volume>
                <fpage>315</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">16714133</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.morel.2005.160">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Prenatal diagnosis for methylmalonic acidemia and inborn errors of vitamin B<sub>12</sub> metabolism and transport.</article-title>
                <source>Mol Genet Metab</source>
                <volume>86</volume>
                <fpage>160</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">16150626</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.nogueira.2008.475">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nogueira</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aiello</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martins</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caruso</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroni</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diogo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le&#x000e3;o</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kok</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deodato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiaffino</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boenzi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danhaive</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeira</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locatelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilarinho</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2008</year>
                <volume>93</volume>
                <fpage>475</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">18164228</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.ostergaard.2007.853">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ostergaard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorensen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsen</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faeroe</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorgrimsson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wibrand</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>853</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">17287286</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.patton.2000.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Patton</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beatty</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wraith</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Optic atrophy in association with cobalamin C (cblC) disease.</article-title>
                <source>Ophthalmic Genet</source>
                <volume>21</volume>
                <fpage>151</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11035547</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.plesa.2011.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Plesa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paquette</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gagnon</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng-Thow-Hing</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>BF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hancock</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coulton</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Interaction between MMACHC and MMADHC, two human proteins participating in intracellular vitamin B metabolism.</article-title>
                <source>Mol Genet Metab</source>
                <volume>102</volume>
                <fpage>139</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">21071249</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.poloschek.2005.497">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Poloschek</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unsold</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Disturbed visual system function in methionine synthase deficiency.</article-title>
                <source>Graefes Arch Clin Exp Ophthalmol</source>
                <volume>243</volume>
                <fpage>497</fpage>
                <lpage>500</lpage>
                <pub-id pub-id-type="pmid">15931548</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.powers.2001.396">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Powers</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cross</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moser</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moser</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency.</article-title>
                <source>Ann Neurol</source>
                <volume>49</volume>
                <fpage>396</fpage>
                <lpage>400</lpage>
                <pub-id pub-id-type="pmid">11261516</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.profitlich.2009.344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Profitlich</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirmse</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wasserstein</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srivastava</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>High prevalence of structural heart disease in children with cblC-type methylmalonic aciduria and homocystinuria.</article-title>
                <source>Mol Genet Metab</source>
                <volume>98</volume>
                <fpage>344</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19767224</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.refsum.2004.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Refsum</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueland</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nexo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McPartlin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engbaek</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneede</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McPartlin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Facts and recommendations about total homocysteine determinations: an expert opinion.</article-title>
                <source>Clin Chem</source>
                <volume>50</volume>
                <fpage>3</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">14709635</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.ribes.1990.412">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ribes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briones</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilaseca</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lluch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campistol</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Methylmalonic aciduria with homocystinuria: biochemical studies, treatment, and clinical course of a Cbl-C patient.</article-title>
                <source>Eur J Pediatr.</source>
                <year>1990</year>
                <volume>149</volume>
                <fpage>412</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">2332011</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.rosenblatt.1997.528">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aspler</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shevell</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pletcher</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fenton</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seashore</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC).</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>20</volume>
                <fpage>528</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">9266389</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.rosenblatt.2001">
              <mixed-citation publication-type="book">Rosenblatt DS, Fenton WA. Inherited disorders of folate and cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease</italic>. 8 ed. New York, NY: McGraw-Hill; 2001:3897-933.</mixed-citation>
            </ref>
            <ref id="cbl.REF.rossi.2001.554">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancheri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiaffino</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fonda</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zammarchi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tortori-Donati</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>22</volume>
                <fpage>554</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">11237984</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.roze.2003.1457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roze</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gervais</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demeret</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogier de Baulny</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zittoun</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoist</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Said</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierrot-Deseilligny</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolgert</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Neuropsychiatric disturbances in presumed late-onset cobalamin C disease.</article-title>
                <source>Arch Neurol</source>
                <volume>60</volume>
                <fpage>1457</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">14568819</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.rutsch.2009.234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rutsch</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gailus</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miousse</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sagne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toliat</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nurnberg</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittkampf</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buers</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharifi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthias</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robenek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquardt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hohne</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasnier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nurnberg</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B<sub>12</sub> metabolism.</article-title>
                <source>Nat Genet</source>
                <volume>41</volume>
                <fpage>234</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19136951</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.shani.1997.1925">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shani</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jimenez-Sanchez</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dean</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valle</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Identification of a fourth half ABC transporter in the human peroxisomal membrane.</article-title>
                <source>Hum Mol Genet.</source>
                <year>1997</year>
                <volume>6</volume>
                <fpage>1925</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">9302272</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.sharma.2007.2097">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prasad</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prasad</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.</article-title>
                <source>Pediatr Nephrol</source>
                <volume>22</volume>
                <fpage>2097</fpage>
                <lpage>103</lpage>
                <pub-id pub-id-type="pmid">17874135</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.sloan.2011.883">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrillo-Carrasco</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandrasekaran</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sysol</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sapp</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorward</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <collab>NIH Intramural Sequencing Center Group</collab>
                </person-group>
                <article-title>Barshop BA, Berry SA, James PM, Champaigne NL, de Lonlay P, Valayannopoulos V, Geschwind MD, Gavrilov DK, Nyhan WL, Biesecker LG, Venditti CP. Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria.</article-title>
                <source>Nat Genet.</source>
                <year>2011</year>
                <volume>43</volume>
                <fpage>883</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21841779</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.smith.2006.138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinney</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Subacute combined degeneration of the spinal cord in cblC disorder despite treatment with B<sub>12</sub>.</article-title>
                <source>Mol Genet Metab</source>
                <volume>88</volume>
                <fpage>138</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">16574454</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.sniderman.1999.675">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sniderman</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giguere</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auray-Blais</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemieux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laframboise</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treacy</surname>
                    <given-names>EP</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program.</article-title>
                <source>J Pediatr</source>
                <volume>134</volume>
                <fpage>675</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">10356133</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.stucki.2012.1410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stucki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Molecular mechanisms leading to three different phenotypes in the cblD defect of intracellular cobalamin metabolism.</article-title>
                <source>Hum Mol Genet</source>
                <volume>21</volume>
                <fpage>1410</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22156578</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.suormala.2004.42742">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zavadakova</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berghauser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wraith</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herwig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis.</article-title>
                <source>J Biol Chem</source>
                <volume>279</volume>
                <fpage>42742</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15292234</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.thauvinrobinet.2008.725">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thauvin-Robinet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roze</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couvreur</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horellou</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruneteau</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonneti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masurel-Paulet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perennou</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreau</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giroud</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Baulny</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraudier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <year>2008</year>
                <volume>79</volume>
                <fpage>725</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18245139</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.tomaske.2001.511">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tomaske</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinemann</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieverding</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Folwer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trefz</surname>
                    <given-names>FK</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>CblC/D defect combined with haemodynamically highly relevant VSD.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>24</volume>
                <fpage>511</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">11596656</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.trefz.2012">
              <mixed-citation publication-type="book">Trefz F, Scheible D, Huemer M, Soumala T, Fowler B, Baumgartner M. Successful prenatal and postnatal treatment in the cobalamin C (CblC) defect. Program #087. Birmingham, UK: Society for the Study of Inborn Errors of Metabolism Meeting. 2012.</mixed-citation>
            </ref>
            <ref id="cbl.REF.tsai.2007.2430">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scharer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerner-Ellis</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Late-onset combined homocystinuria and methylmalonic aciduria (cblC) and neuropsychiatric disturbance.</article-title>
                <source>Am J Med Genet A</source>
                <volume>143A</volume>
                <fpage>2430</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17853453</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.tschudy.2012">
              <mixed-citation publication-type="book">Tschudy MM, Arcara KM. <italic toggle="yes">The Harriet Lane Handbook.</italic> Johns Hopkins Hospital. Philadelphia, PA: Mosby Elsevier; 2012.</mixed-citation>
            </ref>
            <ref id="cbl.REF.tuchman.1988.1052">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tuchman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Vitamin B<sub>12</sub>-responsive megaloblastic anemia, homocystinuria, and transient methylmalonic aciduria in cblE disease.</article-title>
                <source>J Pediatr</source>
                <volume>113</volume>
                <fpage>1052</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">3193313</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.ubbink.2000.233">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ubbink</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Assay methods for the measurement of total homocyst(e)ine in plasma.</article-title>
                <source>Semin Thromb Hemost</source>
                <volume>26</volume>
                <fpage>233</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">11011841</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.van_hove.2002.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Hove</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Damme-Lombaerts</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grunewald</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Damme</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnout</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy.</article-title>
                <source>Am J Med Genet</source>
                <volume>111</volume>
                <fpage>195</fpage>
                <lpage>201</lpage>
                <pub-id pub-id-type="pmid">12210350</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.wang.2009.189">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qiu</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>YF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>XL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>XF</given-names>
                  </name>
                </person-group>
                <article-title>Analysis of gene mutations in Chinese patients with methylmalonic acidemia and homocysteinemia.</article-title>
                <source>Zhonghua Er Ke Za Zhi.</source>
                <year>2009</year>
                <volume>47</volume>
                <fpage>189</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">19573432</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.watkins.1989.427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Functional methionine synthase deficiency (cblE and cblG): clinical and biochemical heterogeneity.</article-title>
                <source>Am J Med Genet</source>
                <volume>34</volume>
                <fpage>427</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">2688421</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.watkins.2014">
              <mixed-citation publication-type="web">Watkins D, Rosenblatt DS. Inherited disorders of folate and cobalamin transport and metabolism. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> Chap 155. New York, NY: McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>. 2014. Accessed 5-2-16.</mixed-citation>
            </ref>
            <ref id="cbl.REF.watkins.2002.143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ru</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philip</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legakis</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilton</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ge</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dore</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosack</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shane</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Hyperhomocysteinemia due to methionine synthase deficiency, cblG: structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173L.</article-title>
                <source>Am J Hum Genet</source>
                <volume>71</volume>
                <fpage>143</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12068375</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.weisfeldadams.2010.116">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weisfeld-Adams</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrissey</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirmse</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salveson</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wasserstein</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuire</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunny</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen-Pfeffer</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caggana</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <article-title>Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2010</year>
                <volume>99</volume>
                <fpage>116</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">19836982</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.wilson.1998.409">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leclerc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saberi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campeau</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shane</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>JA</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Functionally null mutations in patients with the cblG-variant form of methionine synthase deficiency.</article-title>
                <source>Am J Hum Genet</source>
                <volume>63</volume>
                <fpage>409</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">9683607</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.yamada.2006.9476">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toraya</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Human methionine synthase reductase is a molecular chaperone for human methionine synthase.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>103</volume>
                <fpage>9476</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">16769880</pub-id>
              </element-citation>
            </ref>
            <ref id="cbl.REF.zavadakova.2002.461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zavadakova</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pristoupilova</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zavad'akova</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>25</volume>
                <fpage>461</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">12555939</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cbl.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cbl.Author_Notes">
          <title>Author Notes</title>
          <p>Dr Carrillo is a pediatrician and biochemical geneticist. She is an attending physician at the NIH Clinical Center and leads the Clinical Group of the Therapeutics for Rare and Neglected Diseases (TRND) Program at the National Institutes of Health.</p>
          <p>Dr Adams is a pediatrician and biochemical geneticist. He is an attending physician at the National Human Genome Research Institute at the National Institutes of Health.</p>
          <p>Dr Venditti is a pediatrician and biochemical geneticist. He is the director of the Organic Acid Disorder Research Unit, an Investigator in the National Human Genome Research Institute and an attending physician at the National Institutes of Health Clinical Center.</p>
        </sec>
        <sec id="cbl.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>21 November 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>11 August 2009 (cd) Revision: targeted mutation analysis for c.271dupA mutation in cblC and prenatal diagnosis for cblD and variants available clinically.</p>
            </list-item>
            <list-item>
              <p>2 June 2009 (cd) Revision: sequence analysis available clinically for <italic toggle="yes">MMADHC</italic> mutations causing cblD, cblD variant 1, and cblD variant 2</p>
            </list-item>
            <list-item>
              <p>25 February 2008 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>22 December 2006 (cpv) Original submission</p>
            </list-item>
          </list>
          <p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <italic toggle="yes">GeneReview</italic> &#x02018;Disorders of Intracellular Cobalamin Metabolism&#x02019; is in the public domain in the United States of America.</p>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="cbl.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Intracellular metabolism of cobalamin. The intracellular metabolism of cobalamin consists on the endocytosis of cobalamin bound to its blood-carrier transcobalamin. Inside the lysosome cobalamin is released from transcobalamin and then transported into the cytoplasm where it undergoes enzyme-mediated reduction (Cbl III to Cbl II) and either mitochondrial adenosylation to form adenosylcobalamin (AdoCbl) or cytosolic methylation to form methylcobalamin.The disorders of intracellular cobalamin metabolism and their corresponding genes (in parenthesis) are:&#x02014;&#x000a0;Disorders associated with combined methylmalonic acidemia and homocystinuria (combined deficiency of AdoCbl and MeCbl): defects in the lysosomal release of cobalamin (cblF and cblJ) and cytosolic conversion of cobalamin (cblC and cblD).&#x02014;&#x000a0;Disorders associated with homocystinuria and low methionine (isolated deficiency of MeCbl): cblD variant 1, cblE, and cblG.&#x02014;&#x000a0;Disorders associated with isolated methylmalonic acidemia (isolated deficiency of AdoCbl): cblA, cblB, and cblD variant 2 (see <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">Methylmalonic Acidemia</related-object>). Modified from <xref ref-type="bibr" rid="cbl.REF.carrillocarrasco.2012.91">Carrillo-Carrasco et al [2012]</xref></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cbl-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="cbl.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Testing algorithm to confirm the diagnosis of a disorder of intracellular cobalamin metabolism in a probandNotes:1. While diagnostic testing is being performed, contact metabolic team and initiate treatment immediately.2. Normal valuesurine MMA: &#x0003c;4 mmol/mol/CrtHcy: 3-13 &#x000b5;mol/Lplasma methionine: ~3-13 &#x000b5;mol/L (varies by age and laboratory)3. <related-object link-type="booklink" source-id="gene" document-id="mma" document-type="chapter">Methylmalonic Acidemia</related-object></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cbl-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
